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Study of a tumor virus unveils a novel function for the miRNA 
biogenesis machinery 
 
Yao-Tang Lin, Ph.D. 
The University of Texas at Austin, 2012 
 
Supervisor: Christopher Sullivan 
 
Kaposi’s Sarcoma-associated Herpes Virus (KSHV) is a human herpesvirus 
associated with cancers. To date, KSHV miRNAs have been mostly identified via 
analysis of cells that are undergoing latent infection. This work presented here is a novel 
approach to profile small RNAs from populations of cells undergoing predominantly lytic 
infection. Using two different next generation sequencing platforms, I cloned and 
sequenced both pre-microRNAs and derivative microRNAs (miRNAs). This analysis 
shows that the vast majority of viral and host 5p miRNAs are co-terminal with the 5 
prime end of the cloned pre-miRNAs, consistent with both being defined by 
microprocessor cleavage. I report the complete repertoire (25 total) of 5p and 3p 
derivative miRNAs from all 12 previously described KSHV pre-miRNAs. Two KSHV 
pre-miRNAs, pre-miRs-K8 and K12, encode abundant derivative miRNAs from the 
previously unreported strands of the pre-miRNA. I identify several novel small RNAs of 
low abundance, including viral microRNA-offset-RNAs (moRNAs), and antisense viral 
miRNAs (miRNA-AS) that are encoded antisense to previously reported KSHV 
pre-miRNAs. This work also shows that much of the KSHV genome is transcribed in 
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both the top and bottom strand orientations during lytic replication. Despite the enormous 
potential to form double-stranded RNA in KSHV-infected cells, I observe no evidence 
for the existence of abundant viral-derived small interfering RNAs (siRNAs). From the 
small RNA deep-sequencing, I also detected a low abundant small RNA fragment (23 nt) 
that maps to a putative hairpin structure (named hairpin K) within the KSHV PAN 
transcript. I demonstrate that hairpin K is a cis-negative regulatory element in PAN. 
It is well-appreciated that viruses utilize host effectors for macromolecular 
synthesis and as regulators of viral gene expression. Viruses can encode their own 
regulators, but often utilize host-encoded factors to optimize replication. This work 
shows that Drosha, an endoribonuclease best known for its role in the biogenesis of 
miRNAs, can also function to directly regulate viral gene expression. Kaposin B (KapB) 
is a KSHV-encoded protein associated with cytokine production and cytotoxicity. I 
demonstrate that in addition to previously known transcriptional mechanisms, differences 
in Drosha levels contribute to low levels of KapB expression in latency and robust 
increases in expression during lytic replication. Thus, KSHV modulates Drosha activity 
differentially depending on the mode of replication. This regulation is dependent on 
Drosha-mediated cleavage, and KapB transcripts lacking the Drosha cleavage sites 
express higher levels of KapB resulting in increased cell death. This work increases the 
known functions of Drosha and implies that tying viral gene expression to Drosha 
activity is advantageous for viruses. 
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 Chapter 1: Introduction 
 
1.1 Prologue 
Many viruses are able to establish long-term symptomless latency in host cells after 
initial infection. Since there are few differences between latently infected cells and 
healthy cells, the immune system cannot recognize and clear these infected cells from 
the body. Although therapy can be effective, the diseases associated with these latent 
viruses are not curable because drugs are designed to target viral products, which are 
not present in latently infected cells. Therefore, understanding how these viruses 
regulate their own genes and their life cycles is key for eradication and cure of the 
associated diseases. Hespesviruses are among these latent viruses and are also very 
common human pathogens that can cause diseases, such as chickenpox, shingles, 
mononucleosis, oral/genital sores, and various cancers. This review focuses on a 
novel mechanism of viral gene regulation and identification of novel small noncoding 
RNAs in Kaposi’s sarcoma associated herpesvirus (KSHV), one of the eight human 
herpesviruses. 
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1.2 Kaposi’s sarcoma associated herpesvirus (KSHV) 
 
1.2.1 Discovery of Kaposi’s sarcoma associated herpesvirus and associated 
diseases 
Kaposi’s sarcoma associated herpesvirus (KSHV) is the causative agent of Kaposi’s 
sarcoma, a cancer in which abnormal spindle cells grow under the skin in the lining of 
the mouth, nose, and throat and can spread to other internal organs and cause these 
organs to fail. It was discovered in 1994 by the group of Yuan Chang and Patrick 
Moore using polymerase chain reaction-based subtractive hybridization between 
AIDS-KS skin lesions and healthy tissues from the same patient (Chang et al., 1994). 
In addition to KS, KSHV is also linked to two B-cell lymphoproliferative disorders, 
namely primary effusion lymphoma (PEL) (Cesarman et al., 1995) and some forms of 
multicentric Castleman’s disease (MCD) (Soulier et al., 1995). AIDS patients, organ 
transplant patients, and immunocompromised individuals are at high risks for 
infection (Luppi et al., 2000). 
 
1.2.2 Classification of KSHV and the tropism 
KSHV is the eighth member of human herpesvirus (HHV-8), classified into the 
rhadinovirus or gamma-2 herpesvirus, within the subfamily of Gammaherpesvirinae. 
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Humans are the only known host of KSHV to date. Therefore, there is currently no 
animal model to study KSHV pathogenesis. Rhadinoviruses have been found in both 
New World monkeys (herpesvirus saimiri) and Old World monkeys (rhesus 
rhadinovirus), and also in mice (murine gammaherpesvirus-68 or MHV-68). Infection 
of laboratory mice by MHV-68 has provided insights into KSHV 
pathogenesis.  KSHV, like other rhadinoviruses, has pirated a number of cellular 
genes from their host cells and incorporate them into the KSHV genome. Unlike other 
human hespesviruses, such as EBV and HSV-1, KSHV is not ubiquitous, and in most 
developed countries only a small population is KSHV positive (Simpson et al., 1996). 
KSHV tropism is very restricted in vivo. The primary target cell for KSHV is the B 
cell. In addition, KSHV can also infect endothelial cells and monocytes infiltrating 
KS lesions in vivo. Surprisingly, KSHV behaves quite differently in vitro since it can 
infect many human cell lines in culture, such as epithelial cells, endothelial cells, 
fibroblasts, and keratinocytes, but not most B cell lymphoma cell lines (Ganem, 
2010). 
 
1.2.3 KSHV genome and two alternative modes of replication 
Inside the virion, KSHV contains a linear double-stranded DNA of approximately 165 
kb (Russo et al., 1996). The ~145 kb long unique region in the center of the genome 
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contains at least 87 genes. Flanked on each end are the tandem terminal GC-rich 
repeats. Although most genes encoded by KHSV are conserved among 
gammaherpesvirses, KSHV also encodes some genes that are not homologous to other 
herpesviruses. These genes are given a K prefix (e.g., K1 to K15), including some 
genes (~18) KSHV obtained from the host cell. For example, ORF K2 encodes a viral 
protein (vIL-6) that is homologous to cellular IL-6. The entry of KSHV viral particles 
into the host cell is triggered by fusion upon binding of KSHV envelope glycoproteins 
H and L to the cellular receptor, namely ephrin receptor tyrosine kinase A2 (EphA2) 
(Hahn et al., 2012). Once in the cell, the linear KSHV genome circularizes in the 
nucleus. The viral episome is bound by a viral protein, called LANA, which also 
binds to cellular histones H2A and H2B, and thus tethers the viral episome to the host 
chromosome (Verma et al., 2007). Like all herpesviruses, KSHV is able to establish 
latency after primary infection. During latent infection, KSHV episomes are 
maintained at low copy numbers (~10-100 copies per cell) in the host cell and only 
replicate once upon cell division utilizing cellular replication machinery (Nador et al., 
1996). To evade immune surveillance, only a limited number of KSHV genes are 
expressed in this phase. These genes are clustered in the small region, called the 
latency associated region. The latent gene products have been shown to regulate 
several cellular processes to enhance cell survival, promote cell cycle progression, 
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and transform infected cells. Latency is the default program for KSHV both in vivo 
and in vitro. Only 1-3% of cultured BCBL-1 cells or KS spindle cells express lytic 
gene products, indicating spontaneous lytic replication. The mechanism of switch 
from latent to lytic replication is still unclear. However, lytic replication can be 
activated under stressed conditions. At this phase, KSHV lytic genes are sequentially 
expressed. This is controlled by the master regulator of lytic infection, RTA, one of 
the immediate early genes. Expression of immediate early genes regulates the 
expression of early genes, whose gene products enable viral DNA replication. Late 
genes are expressed following viral DNA replication. The assembly of viral 
nucleocapsids then takes place and virions are formed and released.  
 
1.2.4 Transcriptional regulation of viral genes during latent infection 
KSHV latently infected cells express only a handful of KSHV genes. These genes 
include v-FLIP (ORF 71), v-Cyclin (ORF 72), latency-associated nuclear antigen 
(LANA; ORF 73), kaposin (ORF K12) and 12 pre-miRNAs (precursor miRNAs that 
are further processed into mature miRNAs) and they are transcribed from two 
constitutively active promoters in the latency associated region (Ensoli et al., 2001). 
ORF71-73 are transcribed from the same promoter on a polycistronic transcript. This 
promoter encodes several transcripts via differential splicing. The second promoter 
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generates a spliced transcript encoding kaposins and can also generate a transcript for 
ORF71 and ORF72. Ten of the 12 pre-miRNAs are encoded in the intronic region of 
the kaposin transcript, whereas two of them are within the mature kaposin transcript 
(Grundhoff et al., 2006a) . 
 
1.2.5 Transcriptional regulation of viral genes during lytic infection 
ORF50 encoded RTA is the master regulator of KSHV lytic replication. RTA is a 691 
amino acid transcriptional activator, which can directly bind to several KSHV 
promoters, drive the expression of these viral genes, and initiate the cascade of lytic 
gene expression (Gradoville et al., 2000). 
 
1.2.6 KSHV miRNAs 
In addition to the latent genes, KSHV also encodes at least 12 pre-miRNAs during 
latency that give rise to at least 25 different miRNAs (24 different 5p or 3p miRNAs, 
and a single-nucleotide-edited miRNA) that are highly conserved (Lin et al., 2010; 
Marshall et al., 2007). 5p-miRNA is the miRNA derived from the 5' arm of the 
precursor miRNA, and 3p-miRNA is the miRNA derived from the 3' arm of the 
precursor miRNA. The pre-miRNAs are clustered in a single ~4 KB region of the 
genome and are encoded in a polycistronic fashion from any of several different 
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transcripts made during latent infection (Cai and Cullen, 2006; Pearce et al., 2005). 
Two of the pre-miRNAs found in this cluster, pre-miR-K12-10 and pre-miR-K12-12, 
are also encoded by an additional transcript that is transactivated during lytic infection 
(Sullivan and Cullen, 2008). Thus, all known KSHV miRNAs are expressed during 
latent infection and those miRNAs derived from pre-miR-K12-10 and 
pre-miR-K12-12 have been shown or are predicted to be further induced during lytic 
replication. Detailed functional roles of the KSHV miRNAs during bona fide 
infection are lacking. Nevertheless, several mRNA targets that are repressed by the 
KSHV miRNAs have been identified (Gottwein et al., 2007; Samols et al., 2007; 
Skalsky et al., 2007; Whitby, 2009; Ziegelbauer et al., 2009). Some of these targets 
include host genes that play a role in angiogenesis, transformation and apoptosis, 
suggesting that the KSHV miRNAs may be involved in the pathogenesis associated 
with KSHV infection.  
 
1.2.7 Kaposin B 
Long before KSHV was identified in 1994, it has been known that cytokines play an 
important role in Kaposi’s sarcoma pathogenesis. It has been shown that high levels 
of cytokines such as IL-6 and IL-1B, are secreted by KS tumor cells in culture and 
stimulate KS tumor cell proliferation (Ensoli et al., 2001; Ensoli and Sturzl, 1998). 
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Kaposin B is a latent protein that is one of the handful viral genes that are expressed 
during latency. But it is atypical because its expression is further upregulated during 
lytic replication (Sadler et al., 1999). Kaposin B is a scaffolding protein. By direct 
interaction with the kinase MK2, Kaposin B activates the p38 MAPK signaling 
pathway (McCormick and Ganem, 2005). One of the consequences is inhibition of a 
degradative pathway that targets AU-rich elements (AREs) containing transcripts, 
including many cytokine mRNAs, and leads to the stabilization of cytokine mRNAs 
(McCormick and Ganem, 2005). Thus, kaposin B promotes the proinflammatory 
microenvironment, which is characteristic of KS lesions. 
 
1.2.8 KSHV host shutoff of gene expression 
Many viruses evolve ways to globally block host gene expression to evade immune 
surveillance and redistribute the cellular machinery for viral replication. This host 
shutoff mechanism is conserved among gammaherpesviruses. During lytic infection, 
KSHV encodes a host shutoff factor SOX (shutoff and exonuclease) to promote rapid 
and global destruction of cellular mRNAs (Glaunsinger and Ganem, 2004b). The 
endonuclease activity of SOX initiates the cleavage of mRNAs in the cytoplasm 
during early translation and then attracts host 5’-3’ exonucleases to degrade mRNAs 
(Covarrubias et al., 2011). The endonucleolytic activity of SOX is site-specific 
9 
 
(Covarrubias et al., 2011), and it has been shown that some of the cellular transcripts 
can escape host shutoff, including transcripts with important roles in the pathogenesis 
of Kaposi’s sarcoma and other KSHV-related diseases (Glaunsinger and Ganem, 
2004a). IL-6 mRNA is one of the few transcripts that are refractory to SOX-mediated 
degradation; expression of IL-6 appears to be pivotal to cell survival or growth in 
KSHV infected cells (Glaunsinger and Ganem, 2004a). 
 
1.3 Small Noncoding RNAs 
 
1.3.1 microRNA biogenesis  
miRNAs have been the subject of enormous interest due to their regulatory roles in 
numerous and disparate biological processes, including viral infection (reviewed in 
(Gottwein and Cullen, 2008; Grey et al., 2008; Nair and Zavolan, 2006; Pfeffer, 2008; 
Samols and Renne, 2006; Sarnow et al., 2006; Sullivan, 2008; Sullivan and Ganem, 
2005). miRNAs are small, approximately 22 nucleotide RNAs that bind to mRNAs 
and regulate gene expression in a post-transcriptional manner  (reviewed in (Bartel, 
2004; Kim, 2005; Vasudevan et al., 2008)). miRNAs are derived from longer primary 
transcripts (pri-miRNAs) that can be thousands of nucleotides long (Cullen, 2004). 
Pri-miRNAs contain at least one approximately 90 nucleotide sequence that folds into 
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a characteristic hairpin secondary structure element, which is recognized and excised 
by the multi-protein nuclear microprocessor complex, giving rise to an approximately 
60 nucleotide hairpin called a precursor miRNA (pre-miRNA) (Bartel, 2004; Kim, 
2005). The pre-miRNA is then exported to the cytoplasm, whereupon it is recognized 
and cleaved by a complex of proteins containing the RNase III-like protein Dicer. 
Dicer cleavage results in a transient, imperfectly complementary double-stranded ~22 
nucleotide RNA, where, one strand becomes stably incorporated into the 
RNA-induced silencing complex (RISC). Typically, one strand is preferentially 
retained in RISC (the guide strand), and the other strand (the star (*) strand), is barely 
detectable due to degradation. Once a miRNA is active within RISC, the complex 
binds to target mRNA transcripts and affects protein expression (Fig 1.1). miRNAs 
are evolutionarily conserved in plants and animals. Although both plants and animals 
utilize miRNAs to post-transcriptionally regulate gene expression through binding to 
their target transcripts, there are some fundamental differences. For examples, animal 
miRNAs repress gene expression by mediating translational inhibition through 
miRNA-binding sites located within the 3’ UTR of the target transcripts. In contrast, 
most plant miRNAs regulate their target transcripts by cleaving at single sites in the 
coding regions of mRNAs. Also, the Drosha gene is absent from plant genomes. In 
11 
 
contrast, plants utilize Dicer-like 1 protein (DCL1) to process both pri-miRNAs and 
pre-miRNAs into mature miRNAs, and both steps occur in the nucleus.  
 
 
 
 
 
 
 
 
 
 
12 
 
 
Fig 1.1 Diagram of canonical miRNA biogenesis. 
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1.3.2 moRNAs and antisense miRNAs 
Recently, two additional classes of small RNA derivatives have been reported from 
pre-miRNA loci. microRNA-offset-RNAs (moRNAs, or moRs), were originally 
described as an abundant class of small RNAs present in the simple chordate Ciona 
intestinalis (C. intestinalis), where almost 50% of all described miRNA loci also 
express moRNAs (Shi et al., 2009). moRNAs arise from the base of the pre-miRNA 
hairpin stem, are approximately 22 nucleotides long, and are thought to be processed 
by the RNAi RNase III components.  moRNAs have also been reported to exist in 
mammalian cells, albeit the frequency of loci that encode them and their absolute 
abundance are considerably lower than in C. intestinalis (Langenberger et al., 2009). 
Additionally, antisense miRNAs (AS-miRNAs) have been described that derive from 
hairpins formed from complementary transcripts to existing pre-miRNAs. 
AS-miRNAs are not simply “noise” derivatives of antisense transcription, since 
several studies report a role for AS-miRNAs in regulating homeotic gene expression 
in Drosophila and possibly mammals (Stark et al., 2008; Tyler et al., 2008). Recently, 
AS-miRNAs have been reported in two herpes viruses, MCMV and HSV-1 (Buck et 
al., 2007; Dolken et al., 2007; Umbach et al., 2008). 
 
1.3.3 siRNAs 
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Small interfering RNAs (siRNAs) are ~21 nucleotide RNAs that are loaded into RISC 
and can also effect gene silencing. Unlike most miRNAs, siRNAs direct a specific, 
irreversible cleavage of their target mRNAs. siRNAs are thought to be RNAi effectors 
that guard against invasive genetic elements such as transposons and viruses (Carthew 
and Sontheimer, 2009; Ding and Voinnet, 2007). Synthetic siRNAs have shown great 
utility as laboratory reagents for knocking down the expression levels of particular 
genes of interest in mammalian cells, including viral gene products (Elbashir et al., 
2001; Gitlin et al., 2002). While all miRNAs are generated from a single-stranded 
primary transcript (with sub-portions folding into imperfect double-stranded hairpins), 
endogenous siRNAs are generated from longer, perfectly complementary 
double-stranded RNA (dsRNA) transcripts. In mammalian cells, there are hundreds of 
known endogenous transcripts that code for miRNAs, however, there are only a few 
clear examples of endogenously-derived siRNAs (Babiarz et al., 2008; Watanabe et 
al., 2008). Recently, Chandriani et al. have utilized genome-wide tiling array to study 
the KSHV lytic transcriptome, and no KSHV specific siRNAs are identified from 
their array data (published after chapter 2 was completed). 
 
1.3.4 miRNAs encoded by viruses 
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So far, there have been no reports of viral-specific siRNAs being produced during 
infection of mammalian cells (Cullen, 2006).  However, some viruses encode for 
miRNAs within their genome. Viral miRNAs have been identified from viruses with 
DNA genomes, including those of the Herpes, Polyoma and Asco virus families 
(Gottwein and Cullen, 2008; Grey et al., 2008; Hussain et al., 2008; Nair and Zavolan, 
2006; Samols and Renne, 2006; Sullivan, 2008; Sullivan and Cullen, 2008). Most 
viral miRNAs have been identified by sequencing of small RNA libraries (Burnside et 
al., 2006; Cai et al., 2005; Cai et al., 2006; Dolken et al., 2007; Dunn et al., 2005; 
Pfeffer et al., 2004; Samols et al., 2005; Umbach et al., 2008; Yao et al., 2007). But, 
computational methods have played a key role in the discovery of numerous viral 
miRNAs (Buck et al., 2007; Cui et al., 2006; Grey et al., 2005; Grundhoff et al., 
2006b; Hussain et al., 2008; Pfeffer et al., 2005; Seo et al., 2009; Seo et al., 2008; 
Sullivan and Grundhoff, 2007; Sullivan et al., 2005; Sullivan et al., 2009). Viral 
miRNAs are capable of targeting host or viral-encoded transcripts, some of which 
have been shown to function in various pro-viral processes, such as evading the host 
immune response and autoregulation of viral gene expression (Sullivan, 2008). 
However, the function of most of the ~140 known viral miRNAs remains unknown. 
Most of the known viral miRNAs derive from members of the Herpes family. All 
herpesviruses undergo two characteristic modes of replication, latent and lytic. During 
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latent infection, only a small subset of viral gene products are expressed. 
Alternatively, the full repertoire of viral genes is expressed during lytic infection, 
culminating in the production of infectious virions and lysis of the cell.  Most 
herpesviral miRNAs were identified from cells that were predominantly undergoing 
latent infection. However, miRNAs have been detected from viruses undergoing 
productive lytic infection with HCMV, MCMV, HSV-1, HSV-2, MDV-1, and 
MDV-2 viruses (Burnside et al., 2006; Cui et al., 2006; Pfeffer et al., 2005; Tang et 
al., 2008; Yao et al., 2007). Interestingly, accumulating evidence suggests that some 
viral miRNAs will play a role in regulating the switch from latent to lytic infection 
(Cullen, 2009; Grey et al., 2007; Murphy et al., 2008). 
 
1.3.5 Drosha auto-regulates its cofactor DGCR8. 
In addition to its role in miRNA biogenesis, Drosha has been shown to directly 
regulate its cofactors DGCR8 (Han et al., 2009). DGCR8 mRNA has been predicted 
to contain two hairpins, whose secondary structures are conserved among species and 
are similar to pre-miRNA. Drosha recognizes and cleaves these two pre-miRNA-like 
hairpins, and thus eliminates DGCR8 mRNA (Han et al., 2009). On the other hand, 
DGCR8 protein stabilizes Drosha protein via direct protein-protein interaction (Han et 
al., 2009). Therefore, the two components of the microprocessor auto-regulate each 
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other to ensure that the ratio of these two proteins is steady. It is noteworthy that very 
few of the hairpin structures in the DGCR8 mRNA are further processed into mature 
miRNAs, indicating the pre-miRNA-like structures in the DGCR8 mRNA are not 
meant to be utilized to generate miRNAs. It also suggests that Drosha might have 
broader substrates in addition to pri-miRNAs. Whereas the role of Drosha in 
autoregulation of DGCR8 is evident, it is still debated whether Drosha plays a general 
role in direct regulation of mRNA stability. Some groups suggest that mRNA 
destabilization by Drosha is exclusive to DGCR8 based on their mRNA profiling 
analysis (Shenoy and Blelloch, 2009), whereas others suggest that there are some 
mRNAs that are subject to direct Drosha regulation (Chong et al., 2010). A recent 
study has shown that DGCR8 binds to hundreds of mRNAs as well as small nucleolar 
RNAs (snoRNAs) and long noncoding RNAs by high-throughput sequencing and 
cross-linking immune- precipitation (HITS-CLIP), which suggests that the 
microprocessor regulates expression of the RNAs. However, direct evidence of gene 
regulation by the microprocessor is still missing. 
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Chapter 2: Small RNA Profiling of KSHV-Infected Cells 
 
2.1 INTRODUCTION 
KSHV encodes for ~87 protein-coding genes, and at least 12 pre-miRNAs that give 
rise to at least 17 different miRNAs (16 different 5p or 3p miRNAs, and a 
single-nucleotide-edited miRNA) (Marshall et al., 2007). The pre-miRNAs are 
clustered in a single ~4 KB region of the genome and are encoded in a polycistronic 
fashion from any of several different transcripts made during latent infection (Cai and 
Cullen, 2006; Pearce et al., 2005). Two of the pre-miRNAs found in this cluster, 
pre-miR-K12-10 and pre-miR-K12-12, are also encoded by an additional transcript 
that is transactivated during lytic infection (Sullivan and Cullen, 2008). Thus, all 
known KSHV miRNAs are expressed during latent infection and those miRNAs 
derived from pre-miR-K12-10 and pre-miR-K12-12 have been shown or are expected 
to be further-induced during lytic replication. Detailed functional roles of the KSHV 
miRNAs during bona fide infection are lacking. However, several mRNA targets that 
are repressed by the KSHV miRNAs have been identified (Gottwein et al., 2007; 
Samols et al., 2007; Skalsky et al., 2007; Whitby, 2009; Ziegelbauer et al., 2009). 
Some of these targets include host genes that play a role in angiogenesis, 
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transformation and apoptosis, suggesting that the KSHV miRNA may be involved in 
the pathogenesis associated with KSHV infection.  
 
Most of the KSHV pre-miRNAs (11 of 12) were originally identified by sequencing 
small RNA libraries from cells predominantly undergoing latent infection (Cai et al., 
2005; Pfeffer et al., 2005; Samols et al., 2005). One exception identified by the Renne 
group was observed by small scale sequencing (a few hundred total amplicons) from a 
library of small RNAs obtained from TPA-treated cells that have an elevated level 
lytic infection (Samols et al., 2005). Additionally, one of the KSHV pre-miRNAs, 
pre-miR-K12-12, was not cloned, but rather was identified by computational methods. 
The derivative 5p arm was confirmed by microarray and Northern blot analyses of 
RNA isolated from cells undergoing latent infection (Grundhoff et al., 2006b). 
Because all of the known KSHV miRNAs cluster within a 4 KB region of the genome 
that is transcribed during latency, it is reasonable to speculate that additional KSHV 
miRNAs may exist in the remaining ~85% of the genome that is actively transcribed 
during lytic infection. In addition, given that many KSHV transcripts made during 
lytic replication are expressed at high levels and have head-to-head orientations and 
overlapping regions, it is possible that lytic replication may trigger an RNAi response 
that could be discovered by mining for KSHV-specific siRNAs. So far, however, 
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there have been no reports that have carefully examined whether KSHV encodes 
small RNAs that are specific to the lytic cycle. Using the 454 and SOLiD platforms 
(Applied_Biosystems, 2009; Hannon, 2006), I have deep-sequenced small RNA 
libraries from cells that are predominantly undergoing latent or lytic infection. Our 
approach involves making multiple libraries of different size classes allowing us to 
systematically clone pre-miRNAs as well as derivative miRNAs. This furthermore 
allows us to identify regions of the genome that are specifically enriched for 
miRNA/siRNA-sizes over other (random degradation) size classes. These studies 
reveal a surprising wealth of transcription throughout the entire KSHV genome and 
map the entire repertoire of KSHV miRNAs and star sequences, some of which are 
abundant but have so far escaped cloning. I also systematically clone and map the 
viral pre-miRNAs. In addition, I report the first viral-encoded moRNA and 
KSHV-encoded AS-miRNAs. Surprisingly, the KSHV AS-miRNAs appear to be 
predominantly expressed during lytic infection, representing lytic-specific KSHV 
miRNA. Lastly, I identify numerous regions of the genome encoding antisense 
transcripts with potential to form dsRNAs, yet I observe no convincing evidence of 
KSHV-specific siRNAs. The implications of these findings to the KSHV replication 
cycle are discussed. 
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2.2 RESULTS 
 
2.2.1 Small RNA profiling reveals regions of the genome are enriched for 19-23 
nucleotide RNAs  
The aim of this study was to determine if KSHV encodes siRNAs or miRNAs specific 
to lytic replication. A caveat to studying lytic replication in PEL cells is that the 
process of viral replication can lead to abundant, non-specific, general degradation of 
RNA. One way to differentiate regions of the KSHV genome that were enriched for 
siRNAs and miRNAs over random degradation fragments, would be to compare the 
number of KSHV 19-23 bp reads versus other size classes present in the libraries for a 
given region of the genome. This logic assumes that regions of the genome that are 
more prone to random degradation will have increases in other size classes of small 
RNAs, not just those that correspond to siRNA and miRNAs. Conversely, regions of 
the genome enriched for siRNA or miRNA production should show an increase in the 
ratio of 19-23mer RNAs over the other size classes. 
 
For most of these experiments, an inducible BCBL-1-derived cell line (TREx 
BCBL-RTA) developed by Jung and colleagues was used. Recently, this cell line was 
shown to be highly inducible into lytic replication by the addition of TPA, ionomycin, 
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and doxycycline (T.I.D.). The BCBL-1 cell line (and its derivatives) is infected with 
KSHV, and was originally derived from primary effusion lymphoma (PEL) cells from 
a patient with advanced HIV disease. Treatment of the TREx BCBL-RTA cells results 
in strong induction of lytic gene expression as judged by multiple assays. Immunoblot 
analysis for proteins specific to (or enriched for) lytic replication (RTA, Kaposin B, 
and K8.1) shows robust induction (Fig. 2.1C). Northern blot analysis shows a strong 
induction of the non-coding RNA PAN (Fig. 2.1D), which is only expressed during 
lytic replication. Finally, flow cytometric analysis of cells for the master lytic switch 
protein RTA (~88% cells positive), or a marker of late gene expression, K8.1 (~48% 
cells positive), clearly shows a large enrichment in the fraction of cells that are 
initiating the lytic cascade of gene expression (Fig. 2.1E).  
 
Next total RNA from the latent population of cells or cells enriched for lytic 
replication was fractionated by size. RNA was isolated from two regions of the 
denaturing gel, including RNA of ~18-26 nucleotides that should include miRNAs, 
random degradation fragments and possibly siRNAs, as well as the RNA that is 
~45-75 nucleotides in length that should include pre-miRNAs, random degradation 
fragments, and possibly other classes of non-coding RNAs (Fig. 2.1A). These RNA 
were ligated to linkers, reverse transcribed and subjected to deep sequencing using the 
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SOLiD platform. In addition, BCBL-1 cells (obtained from ATCC) were examined. 
Untreated BCBL-1 cells predominantly undergo latent infection whereas treatment 
with sodium butyrate increases the proportion of cells undergoing lytic infection. 
Small RNA libraries were generated from both treated and untreated BCBL-1 cells. 
Immunofluorescent and flow cytometric analyses of sodium butyrate-treated cells for 
the viral protein K8.1 confirmed an enrichment of cells undergoing lytic infection. 
Total RNA was harvested from each population of cells (treated and untreated) and 
RNAs in the size range of ~16 to 70 nucleotides were isolated. Appropriate linkers 
were added, and after reverse transcription, the cDNAs were sequenced on a 454 
pyrophosphate sequencer. A combined total of ~250 thousand reads was obtained for 
the 454 analysis of the BCBL-1 cells (~0.43% mapping to KSHV genome, Table 2.1) 
and ~ 98 million reads from SOLiD sequencing of the TREx BCBL-RTA cells (~5% 
mapping to the KSHV genome, Table 2.2). Because of the significantly greater depth 
attained by the SOLiD analysis, much of this paper utilizes this data, but, several 
findings were buttressed by the 454 analysis (see below).   
 
The results were filtered to identify reads mapping to the KSHV genome. Plotting the 
fraction of SOLiD reads that were 19-23 nucleotides in length relative to the reads in 
the larger size class (~45-75 nucleotides) revealed a single region of the genome 
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greatly enriched for miRNA/siRNA-sized RNAs (Fig. 2.2A & B). Notably, this part 
of the genome (nucleotide positions 117,780-122,161), encodes the previously 
described KSHV polycistronic miRNA cluster. The vast majority of the reads in this 
region are in the same orientation as the KSHV miRNAs. I can detect distinct start 
sites of the 5p and 3p miRNAs for all 12 KSHV pre-miRNA loci (Fig. 2.3). This 
result validates the ability of my approach to detect viral miRNAs from cells 
undergoing latent or lytic infection. Nearly identical results were obtained (albeit with 
much less coverage) when the 454 data was analyzed in a similar manner (Fig. 2.4). 
Together, these data suggest that no other regions of the KSHV genome encode 
miRNAs expressed to the same level as the previously described polycistronic 
miRNA cluster. 
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Figure 2.1 Experimental strategy employed. (A) Two different sizes of small RNAs 
(18-25 nt, enriched for miRNAs, and 45-75 nt, enriched for pre-miRNAs, were 
size-fractionated by denaturing polyacrylamide gel electrophoresis, ligated to linkers, 
and then converted to cDNA. After amplification, the cDNAs were sequenced by ABI 
SOLiD. Computational methods were utilized to map reads corresponding to the 
KSHV genome (NC_009333.1), and (B) the desired size class (19-23 nucleotides) 
was plotted over other sizes present in the library to determine regions of the genome 
enriched for specific classes of small RNAs. (C) Western immunoblot analysis 
demonstrating induction of markers for lytic replication with various drug regimens 
for 48 hours. The TREx –RTA BCBL-1 cells are highly inducible for lytic replication 
upon treatment with three drugs: TPA, Ionomycin (ION), and Doxycycline (DOX) 
(T.I.D.). KapB, RTA, K8.1 correspond to KSHV proteins that are known to be 
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induced during lytic replication. “Control” indicates loading control, a >80 kD band 
that cross-reacts with the anti-K8.1 antibody. (D) Northern blot analysis shows that 
the Polyadenylated Noncoding RNA (PAN), a lytic-specific transcript, is robustly 
induced when treated with the triple drug regimen (T.I.D.) for 48 hours. (E) Flow 
Cytometric analysis shows the percentage of individual cells expressing RTA or the 
late lytic protein K8.1. The dark line indicates cell treated with the triple drug regimen 
(T.I.D.)   
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Table 2.1 454 reads of small RNAs from BCBL-1 cells undergoing latent 
infection or stimulated to undergo lytic infection. Cloned sequences were filtered 
to identify RNAs between 19-23 nt and were then BLASTed against the KSHV 
genome, known KSHV miRNAs, or human miRNAs. The number of amplicons are 
listed, parentheses indicate total number of unique miRNA sequences represented in a 
particular class.  
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Table 2.2 The mapping results from the ABI small RNA analysis pipeline (v0.5). 
Reads matching tRNA and rRNA are indicated. The remaining reads were then 
mapped to known KSHV and human pre-miRNAs. Any remaining reads were then 
mapped to the human and KSHV genomes (NCBI36 and EMBL NC_009333.1, 
respectively). “SU”  and “SI” refer to the small uninduced and induced (for lytic 
replication) libraries, respectively. “LU” and “LI” refer to the large uninduced and 
induced (for lytic replication) libraries, respectively. miRNAs are enriched in the 
small libraries, while pre-miRNAs are enriched in the long libraries. 
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Figure 2.2 Plotting the ratio of 19-23 nucleotide RNAs over other size classes 
mapping to the KSHV genome identifies regions enriched for small RNAs of 
interest. (A) Uninduced. (B) Induced. (C) Uninduced, 100x zoom on Y axis. (D) 
Induced, 100x zoom on Y axis. RNA libraries from the uninduced (A, C) or 
lytic-induced RNA (B, D) were analyzed. A, B, Low resolution view demonstrates the 
extreme enrichment of reads mapping to the KSHV pre-miRNA loci (labeled “f”). C, 
D, Zooming in reveals additional regions enriched for 19-23 nucleotide RNAs (“a” – 
e”, “g”).  Window analysis of reads that mapped to KSHV genome was plotted using 
a window length of 500 nt (W = 500; See Methods section for more details). Regions 
with a greater number of short reads than long reads marked “a”, “b”, “c”, “d”, “e”, 
and “f “were selected for further analysis. Arrows at side of plots indicate orientation 
of reads that are plotted (rightward arrow indicates top strand transcripts, 
leftward-facing arrows indicates the bottom strand transcripts.)  
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Figure 2.3 KSHV miRNAs. 
Sequenced frequency for known KSHV miRNA loci. 3p derivative miRNA 
corresponds to left peak, 5p derivative miRNA correspond to right peak. (SU = Short 
uninduced library; SI = Short induced library).  
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Figure 2.3 KSHV miRNAs. 
Sequenced frequency for known KSHV miRNA loci. 3p derivative miRNA 
corresponds to left peak, 5p derivative miRNA correspond to right peak. (SU = Short 
uninduced library; SI = Short induced library).  
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Figure 2.4 Density map of cloned small RNAs across the KSHV genome. The 
KSHV genome (NC_009333) was binned into 2000 bp fragments, overlapping by 
1000 bp, to create a blast database. The sequencing reads were size-filtered into 19-23 
nt or non-19-23 nt classes (~16-18-nt & ~25-70-nt), and then BLASTed against the 
KSHV binned database. The19-23 mers are represented with blue triangles, whereas 
other size classes are represented by yellow circles. Cloned small RNAs from cells 
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undergoing latent (A) infection or lytic (B) infection are indicated. Blue arrows 
diagram the location of the known KSHV pre-miRNAs. 
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2.2.2 Cloning of the KSHV pre-miRNAs and all the derivative 5p and 3p 
miRNAs 
Previous studies have identified 12 KSHV pre-miRNAs that give rise to at least 17 
different derivative miRNAs. The SOLiD sequencing data was analyzed to address 
three questions: (1) Can the pre-miRNAs that give rise to the known KSHV miRNAs 
be cloned? (2) Can the 5p and 3p derivatives of all the KSHV pre-miRNAs be 
identified? (3) Are any novel KSHV miRNA derivatives likely to be biologically 
active?  
 
Previous studies have not attempted to systematically clone the pre-miRNAs 
represented in a population of virally-infected cells. Computational analysis was used 
to identify the amplicons present in the larger size class library (45-75 nucleotides) 
that map to known human or KSHV pre-miRNA loci (Tables 2.3, 2.4). Derivative 
pre-miRNA (from the long uninduced or induced for lytic replication) (LU, LI) and 
miRNA reads (from the short uninduced or induced for lytic replication) (SU, SI) 
were mapped onto individual, specific miRBase-annotated pre-miRNA sequence 
positions (Figs. 2.5, 2.6). This analysis identified the KSHV pre-miRNA for 10 of the 
12 known pre-miRNAs (Figs. 2.5, 2.6). Interestingly, some of the KSHV 
pre-miRNAs were significantly more abundant than others, but pre-miRNA 
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abundance did not necessarily correlate with miRNA abundance (Figs. 2.5, 2.6, 2.7). 
Of note, the pre-miR-K12-5 was the fourth most abundant KSHV pre-miRNA that 
was cloned, despite the fact that its derivative miRNAs are among the lowest KSHV 
miRNAs represented in the library. This observation is consistent with previous 
reports showing that the pre-miRNA for the BCBL-1-encoded miR-K12-5 is 
inefficiently processed into miRNAs (Gottwein et al., 2006). For both viral and 
human pre-miRNAs, the 5’ end of the most abundant pre-miRNA amplicons was 
almost always co-terminal with the 5’ end of the derivative 5p miRNA. Consistent 
with the current microprocessor model (Seitz and Zamore, 2006), these data strongly 
suggest that processing of the pre-miRNA defines the 5’ end of the derivative 5p 
miRNAs. Thus, pre-miRNAs are “clonable”, and the 45-75 nucleotide libraries (LU 
and LI) contain pre-miRNAs, whereas our 19-23 libraries (SU and SI) contain 
derivative 5p and 3p miRNAs. Consistent with this, the 454 library also contained a 
small number of pre-miRNAs whose sequences were represented in their entirety 
(Fig. 2.13). 
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Table 2.3 The mature microRNAs derived from the 12 previously described 
KSHV pre-miRNAs. These counts were obtained by mapping reads to the KSHV 
precursors (miRBase version 13.0, gff-version 2), filtering for matches with 3 or less 
mismatches, and filtering by length (SU and SI : 18-25 nt, LU and LI: >=30 nt). The 
sequences and lengths for the mature miRNAs were extrapolated from the KSHV 
pre-miRNA by taking into account the genomic coordinates to which the largest 
number of reads (either SU or SI) mapped and the mean lengths of the matches. Note, 
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the 3p miRNAs rarely score in the LU or LI libraries because the SOLiD reads cut off 
at 35 nucleotides. (Thus, reads of pre-miRNAs will encompass the 5p miRNAs, but 
not the 3p miRNAs). “SU”, “SI”, “LU”, and “LI” labels are described in the legend to 
Table 2.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
 
Table 2.4 Probes and Primers used in this study. 
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Figure 2.5 Read coverage of 4 exemplary KSHV miRNAs and pre-miRNAs 
mapping to miRBase-annotated pre-miRNAs. Pre-miRs-K12-8 and 12 both 
express abundant 5p and 3p derivative miRNAs that were missed in previous studies. 
Pre-miRs-K12-5, 10a, and 12 have flanking moRNAs. The start position of the reads 
(0) is given relative to the start of the most abundant precursor mapped in our libraries 
along with the mean length of the reads (indicated by colored/black horizontal lines). 
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The four vertical lines denote the 5p start site, 5p end site, 3p start site, and the 3p end 
site. The reads corresponding to the pre-miRNA have a maximum length of 35 
nucleotides (the upper cut-off of read length available from current SOLiD platform). 
SU refers to small RNA library (19-24 nucleotides) from uninduced cells, SI refers to 
the small RNA library from cells induced to initiate lytic replication, LU refers to 
large RNA library (45-75 nucleotides from uninduced cells, LI refers to the long RNA 
library from cells induced to initiate lytic replication. “moRNA” indicates reads 
corresponding to the moRNAs of pre-miRs--K12-10 & 12). Note: reads are plotted as 
a log scale to show lower abundance pre-miRNA derivatives. 
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Figure 2.6 Read coverage for all 12 KS precursors. 
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Figure 2.6 Read coverage for all 12 KS precursors. The start position of the reads 
(filtered by length and mismatches) is given relative to the start of the 
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miRBase-annotated precursor (0) along with the mean length of the reads. The four 
vertical lines denote the 5p start site, 5p end site, 3p start site, and the 3p end site. 
Note: reads are plotted as a log scale to show less frequent pre-miRNA derivatives. 
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Figure 2.7 Northern blot analysis of KSHV-encoded miRNAs demonstrates the 
5p and 3p miRNAs are detectable from most KSHV pre-miRNA loci. For a few 
pre-miRNAs, only one strand was detectable as a miRNA (pre-miR-K12-1, 2, 4, and 
6). For the others, the miRNAs were abundant enough that I could detect both the 5p 
and 3p derivatives. The left lane (U) correspond to RNA from untreated cells 
(predominantly latent), the right lane (I) corresponds to RNA from cells enriched for 
lytic replication. Arrows indicate miRNAs migrating at ~22 nucleotides. The loading 
control, shown in bottom panels, is ethidium bromide-stained low molecular weight 
RNA. 
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2.2.3 Some KSHV “star” miRNAs* are abundant and biologically active 
Each pre-miRNA typically gives rise to two predominant products, the 5p and 3p 
miRNAs, derived from each arm of the pre-miRNA hairpin. Typically one arm (the 
“miRNA guide strand”) is favored to be stably-incorporated within RISC and is more 
abundant than the other arm derivative. The less abundant derivative, (the “star 
miRNA* passenger strand”) is not typically thought to be the driver of biological 
activity. However, unlike most host-derived miRNAs, several viral pre-miRNAs give 
rise to abundant 5p and 3p miRNAs, and at least some viral star miRNAs are 
biologically active (Seo et al., 2008; Sullivan et al., 2005). As previously mentioned, 
KSHV is known to encode 17 derivative miRNAs from 12 pre-miRNAs. The libraries 
were searched to determine if any previously un-annotated KSHV miRNA sequences 
were represented. All 25 5p and 3p derivatives (including the single edited miRNA) 
were cloned and mapped (Table 2.3, Figs. 2.5, 2.6). As expected, many of the miRNA 
derivatives represented in these libraries that previously escaped detection were of 
low abundance and presumably * sequences (miRs-K12-1-3p, 2-3p, 5-5p, 7-5p, 
10-5p, & 11-5p). Nonetheless, many of the KSHV miRNA* derivatives are more 
abundant than some non-star human miRNAs. Furthermore, most KSHV miRNA 
derivatives represented in these libraries are detectable by Northern blot (Fig. 2.7). Of 
note, K12-9-5p was previously annotated as the star derivative (Griffiths-Jones, 
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2006), but is the more abundant amplicon represented in our libraries and is robustly 
detectable by Northern blot analysis (Table 2.3, Fig. 2.7). Interestingly, both 
K12-8-5p and K12-12-3p had previously escaped detection but were extremely 
abundant in our libraries and robustly detectable by Northern blot analysis (Table 2.3, 
Figs. 2.5, 2.7). Combined, these data argue that some KSHV miRNA derivatives that 
were previously unreported are abundant and might have biological activity. 
 
To test whether K12-12-3p could have biological activity, luciferase reporters that 
were constructed to have binding sites complementary to either the 5p or 3p K12-12 
derivatives. Negative control reporters with mutations in the region complementary to 
the miRNA seed also were prepared. Transfection of an irrelevant construct encoding 
miR-K12-4 had little effect on luciferase activity from either the K12-5p, & 3p 
reporters or the negative control reporters (Fig. 2.8C, & data not shown). In contrast, 
transfection of a vector encoding the K12-12 pre-miRNA reduced luciferase 
expression from both reporter vectors by approximately 50%. An additional negative 
control experiment, whereby the construct encoding the K12-12 pre-miRNA was 
transfected with an irrelevant luciferase reporter containing binding sites to the JCV 
viral miRNA, showed no effect on luciferase activity (data not shown). Combined, 
these data argue that the effects of the K12-12 5p and 3p miRNAs are specific. 
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However, the relative activity of K12-12 5p and 3p during infection is uncertain until 
bona fide mRNA targets are identified.  Thus, the K12-12-3p miRNA is abundant 
and likely active in KSHV-infected cells. 
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Figure 2.8 Multiple specific small RNAs derived from pre-miR-K12. (A) 
Predicted secondary structure of pre-miR-K12-12. The two derivative miRNAs, 
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K12-12-5p (Griffiths-Jones, 2006) and K12-12-3p (reported in this study) are 
indicated with black bars. The K12-12 moRNA is indicated with a gray bar. (B) 
Northern blot analysis of miR-K12-12 5p and miR-K12-12-3p. Two models of lytic 
induction were analyzed. RNA from regular BCBL-1 cells that were predominantly 
undergoing latent infection (untreated) or treated with sodium butyrate (NaB) to 
induce lytic replication was used. RNA from the non-isogenic, uninfected 
KSHV-negative BJAB cells serve as a negative control. Additionally, RNA from 
untreated, predominantly latent, or triple drug-treated T.I.D. (lytic-enriched) 
TREx-RTA BCBL-1 cells was analyzed. Arrows indicate miRNA band. (C) 
Luciferase assay demonstrates both miRNA derivatives of pre-miR-K12-12 are active. 
Renilla luciferase reporter vector with 4 copies of miR-K12-12-5p or miR-K12-12-3p 
target sites were co-transfected with the pre-miR-K12-4 or pre-miR-K12-12 
expression vectors. As a negative control, an identical reporter containing mutations 
in the seed region was also analyzed. Normalization control vectors (firefly luciferase 
vector) were also co-transfected as a control for transfection efficiency. (D) 
Histogram of read coverage mapping to miR-K12-12-5p, miR-K12-12-3p and K-12 
moRNA from the small induced (18-25, SI) library. A histogram of reads mapping to 
pre-miR-K12-3 is shown for comparison.  
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2.2.4 Discovery of a viral-encoded moRNA 
moRNAs are derived from the extreme ends of pre-miRNA loci, and in mammalian 
cells, are typically of significantly lower abundance than the miRNA derivatives. So 
far, moRNAs have not been reported to be encoded by viruses. Most of the KSHV 
pre-miRNA loci (11 of 12) did not show abundant read patterns indicative of 
moRNAs (Figs. 2.8D, 2.3, 2.6). However, a clear exception was pre-miR-K12-12 
(Fig. 2.8D). As is typical for most of the KSHV pre-miRNAs, the histogram of reads 
covering the pre-miR-K12-12 locus shows distinct peaks for the 5p and 3p derivative 
miRNAs. Additionally, a small peak, consistent with a moRNA derivative, is evident 
at the 3’ end of pre-miR-K12-12 (Fig. 2.8D). The number of reads corresponding to 
the moRNA was relatively few, around ~ 100 total reads. This number is at the lower 
end of what I observe for the host miRNAs that are represented in our libraries, and 
much lower than the K12-5p and 3p miRNAs (consistent with the low processing 
efficiencies reported for other mammalian-derived moRNAs. Repeated attempts to 
express this moRNA using the plasmid construct that expresses pre-miR-K12 (and 
miRNA derivatives) failed to demonstrate a moRNA-corresponding band via 
Northern blot analysis. This result suggests that the K12 moRNA is very inefficiently 
processed or and/or not amenable to exogenous expression and raises the possibility 
that moRNAs are non-functional miRNA processing intermediates. Finally, I note that 
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pre-miR-K12-4, 5, 6 & 10 also contain reads consistent with 3’ or 5’ moRNAs (Figs. 
2.5, 2.6). I conclude that KSHV encodes multiple, albeit low abundance, moRNAs. 
 
2.2.5 Discovery of KSHV antisense miRNAs expressed during lytic replication 
From our earlier size ratio analysis (Fig. 2.2A & B), it was clear that no regions of the 
KSHV genome encoded miRNAs as abundant as the previously described 
polycistronic miRNA cluster. To explore the possibility that less abundant 
RNAi-associated RNAs (miRNA/siRNAs) may be expressed during infection, I 
altered the scale of my previous analysis to include regions of the genome that 
showed only slight enrichment in 19-23 nucleotide RNAs over other size classes (Fig. 
2.2C & D).  As before, 19-23 nucleotide RNAs from the smaller library were 
compared to other size classes (45-75 nucleotides, from the larger library). At this 
scale, a general trend across the KSHV genome is evident, whereby most regions are 
enriched for the non-miRNA-size classes (45-75 nucleotide RNAs). I do not detect 
regions of the genome that are enriched for 19-23 nucleotide RNAs in both the sense 
and antisense orientations– that would be indicative of siRNAs. I therefore conclude it 
is unlikely that abundant siRNAs derived from longer antisense dsRNAs are robustly 
made during KSHV lytic infection.  
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During lytic replication, seven regions of the genome show peaks where 19-23 
nucleotide RNAs of a single orientation are overrepresented during lytic infection 
(labeled “a” through “g” on Fig. 2.2D).  I applied an additional filter to eliminate 
potentially artifactual peaks that required each region to also be enriched for 19-23 
nucleotide RNAs over >24 nucleotide RNAs present in the small library (another 
filter for random degradation fragments).  This added filter removed region “e” from 
further consideration. Peak “f” is readily accounted for as the KSHV latent miRNA 
cluster. Of the remaining peaks, only “d” and “g” had read patterns that were 
consistent with miRNAs (reads mapping to the appropriate miRNA size and confined 
to one or a few 5’ and 3’ termini). Peaks “a”, “b”, &”c” will be addressed in the 
Discussion section. Peak “d” maps to the coding region of ORF 45. Northern blot 
analysis for this region was inconsistent, and the flanking regions of this peak are not 
predicted to fold into a pre-miRNA-like structure. Therefore, I abandoned further 
experiments in this region of the genome. 
 
Peak “g” is notable because it encompasses a predominantly 22 nucleotide RNA that 
maps antisense to miR-K12-4-5p (Fig. 2.9A). Further, previous reports have identified 
antisense miRNAs in other Herpesviruses. As this putative miRNA differs from 
miR-K12-4-3p by only six nucleotides (Fig. 2.9B), I examined whether there was any 
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preference for sequencing errors in these six residues that would be suggestive of 
mis-annotation due to a computational artifact. No preference for mismatches at these 
particular six nucleotides were observed, suggesting that the reads corresponding to 
the AS miRNA are not simply sequencing errors of miR-K-12-4-3p. Next, the 
secondary structure of transcripts from this region was predicted. A hairpin secondary 
structure was predicted antisense to pre-miR-K12-4 (Fig. 2.9A). The location of the 
AS miRNA maps to a position on the predicted hairpin precursor that is completely 
consistent with pre-miRNA structure and derivative miRNA processing (Fig. 2.9A). 
To determine if transcripts that span this region could be efficiently processed into 
miRNAs, the portion of the genome corresponding to the predicted pre-miRNA 
hairpin and flanking regions (~200 bp in total) was sub-cloned into a heterologous 
expression vector. The vector was transfected prior to isolation of total RNA. 
Northern blot analysis confirmed robust and specific processing of this miRNA (Fig. 
2.9C). This miRNA, then was tested for biological activity within the RISC complex. 
A reporter containing perfectly complementary binding sites or a negative control 
reporter containing 5 nucleotide point mutations (complementary to the seed region) 
was co-transfected with the miRNA-expressing vector. Luciferase assays conducted 
on lysates harvested from these cells demonstrate robust and specific knockdown of 
the target reporter (Fig. 2.9D). These data show that driving transcription of this 
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genomic region leads to efficient processing of a pre-miRNA and biological activity 
of the derivative miRNA within RISC. A bona fide, lytic-replication- specific miRNA 
was confirmed at low levels of expression (miR-K12-4-AS.) 
 
Other KSHV pre-miRNA loci also were examined AS miRNAs. Mining these 
libraries for evidence of miRNAs or pre-miRNAs failed to uncover any additional 
reads for the miR-K12-4-AS locus. However, three additional KSHV AS miRNAs 
were identified– two from the 5p or 3p arms of the same AS pre-miRNA, 
pre-miR-K12- 2-AS (Fig. 2.10). These KSHV miRNA loci were designated as:  
“K12-8-AS-5p,” “K12-2-AS-5p” and “K12-2-AS-3p”. Reads for at least one 
AS-pre-miRNA, pre-miR-K12-8, was complementary to miR-K-12-8 (Fig. 2.10). 
These results strongly imply that similar to host miRNAs, the KS AS miRNAs are 
derived via normal microprocessor/Dicer miRNA machinery processing. 
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Figure 2.9 Expression and activity of an antisense miRNA complementary to the 
pre-miR-K12-4 locus. (A) Predicted secondary structure of the pre-miR-K12-4 and 
pre-miR-K12-4-AS. Mapped 5p derivative miRNAs are indicated with a black bar, 
mapped 3p derivative miRNAs are indicated with a gray bar. (B) Sequences of 
miR-K12-4 and miR-K12-4-AS. Nucleotide differences between K12-4-3p and 
K12-4-AS-3p are indicated in bold/underline. (C) Northern blot analysis of 
miR-K12-4-AS. Cells were transfected with a vector expressing either miR-K12-10 or 
miR-K12-4-AS. RNA was harvested and hybridized with a probe complementary to 
miR-K12-4-AS. (D) miR-K12-4-AS is active with RISC complex. Expression of a 
plasmid expressing miR-K12-4-AS downregulates expression of a reporter containing 
complementary binding sites, but not a control reporter in which the seed region was 
mutated. 
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Figure 2.10 Additional KSHV AS miRNAs identified in this study. A. Secondary 
structure prediction of KS AS miRNAs. B. Number of reads representing miRNAs 
(“S” fraction) or pre-miRNAs (“L” fraction). Note that for K-12-2-AS both the 5p and 
3p derivatives were cloned, displaying a two nucleotide overhang when mapped back 
to predicted pre-miRNA precursor, indicative of Drosha / Dicer processing. Five 
reads were mapped from the long (L) fraction. These reads had identical start sites to 
the K12-8-AS-5p, indicative of cloned pre-miRNAs. 
57 
 
2.2.6 Small RNA profiling reveals transcripts throughout the genome originating 
from both the bottom and top strands.   
The discovery of KSHV AS miRNAs is noteworthy since it implies the existence of 
previously unknown longer precursor transcripts that are encoded antisense and 
complementary to the KSHV miRNA cluster. To determine if such transcripts exist, 
all the transcripts represented in our libraries were plotted in the bottom or top strand 
orientations (Fig. 2.11A). Most of the reads from the latently-infected cells 
correspond to the KSHV miRNA cluster (Fig. 2.11A).  Since much of the genome is 
only transcriptionally active during lytic replication, it was not surprising to observe a 
dramatic increase in the number of reads obtained from cells undergoing lytic 
replication (compare lower histogram plotted below the genome map to the upper 
histogram). Presumably, many of these are random degradation fragments of larger 
transcripts. Strikingly, during lytic replication, antisense transcription in regions 
spanning almost the entire genome was detected. This includes the regions of the 
genome that encode the latent transcripts and the latent miRNA cluster, which 
previously were not known to encode antisense transcripts. To confirm that antisense 
transcription occurs in many regions of the genome, directional reverse transcription 
was used and followed by PCR. Ten regions of the genome were chosen that were 
only known to encode transcripts of a single orientation or no transcripts at all (Fig. 
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2.12). Additionally, a positive control was included to detect a region of the genome 
encompassing a portion of ORF50/RTA, known to encode bottom and top strand 
transcripts. Directional RT-PCR confirmed that eight of these regions (including the 
ORF50/RTA control) encode detectable sense and antisense transcripts during lytic 
replication (Fig. 2.11B). Regions that scored positive for antisense transcription had to 
meet several criteria. First, there had to be a distinct band of the appropriate size in 
cells undergoing lytic replication. Second, there had to be no band detectable from 
several different negative controls, including RNA harvested from lytic cells in which 
RT was omitted from the reaction, RNA harvested from uninfected cells (BJAB) that 
were treated with the same induction drug regimen, and RNA from cells undergoing 
lytic replication that was primed with any of 10 different irrelevant RT primers from 
an alternative region of the KSHV genome (Fig. 2.12). Importantly, directional 
RT-PCR confirmed that the miRNA cluster region of the genome not only undergoes 
robust transcription in the same orientation as the miRNAs, but also detectable 
transcription antisense to the latent KSHV miRNAs (Fig. 2.11B). Thus, by several 
criteria, unknown transcripts exist that are antisense to the KSHV miRNA cluster that 
could give rise to the AS pre-miRNAs. Furthermore, lytic replication produces 
numerous previously unknown transcripts that are antisense to the abundant, 
previously characterized KSHV transcripts. 
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Figure 2.11 Antisense transcription is detected throughout the KSHV genome. 
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Figure 2.11 Antisense transcription is detected throughout the KSHV genome. A. 
Coverage plot of all reads mapping to the KSHV genome.  Sequenced frequency of 
reads that mapped to the KSHV genome for the combined short and long fractions of 
uninduced and induced samples is plotted on a log scale.  Each graph is divided into 
top strand transcripts (top, rightward arrow) and bottom strand transcripts (bottom, 
leftward arrow) as indicated on the right side of the figure. Directional RT-PCR 
locations are indicated with a line below the genome map (positions 5041-5252, 
12283-12496, 25831-26039, 73712-73929, 87182-87451, 104671-104880, 
121579-121820, 123061-123269). Genome annotations are based on NCBI reference 
sequence NC_009333.1.  (B) Directional RT-PCR confirming previously unreported 
antisense transcription upon KSHV lytic infection. Eight regions only known to have 
transcription in one orientation were tested for antisense transcription. RNA from 
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un-infected BJAB cell total was used as a negative control. The direction of the RT 
primer used is indicated at top of figure. No RT control was included to exclude the 
possibility of genomic DNA contamination. To control for possible RT mis-priming, 
all regions shown scored negative in the PCR assays when any of 10 additional 
control RT primers were used (Figure 2.12).  
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Figure 2.12 Directional RT PCR for less abundant KSHV antisense transcripts is 
specific. Only the specific RT primer results in a PCR-generated band for regions of 
the KSHV genome that score positive for antisense transcription. Thus, 10 sets of 
control oligonucleotides fail to generate RT products that are amplified by PCR 
primers, suggesting RT mis-priming is unlikely to account for the bands detected. 
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2.3 DISCUSSION 
 
2.3.1 Identification of previously undescribed abundant miRNA derivatives  
In this work, two different methods were used to generate small RNA libraries, and 
sequenced by either the 454 or SOLiD sequencing techniques. Sequencing at this 
depth, 8 new derivative miRNAs encompassing all 25 derivatives that are known or 
would be predicted to be encoded by the previously reported 12 KSHV pre-miRNAs 
were identified (Table 2.3). Notably, based on Northern blot analysis and relative 
amplicon numbers, two of the previously unreported KS miRNAs represented in the 
libraries, K12-8-5p and K12-12-3p, are highly abundant (Table 2.3 & Figs. 2.7 & 
2.8). At present, the reasons for previous failure to detect miR-K12-8-5p are unclear. 
miR-K12-12-3p contains a BAN I restriction site that was used in the studies that 
identified 11 of the 12 abundant KSHV pre-miRNAs and derivatives (Cai et al., 2005; 
Pfeffer et al., 2005; Samols et al., 2005). Therefore, miRK-12-12-3p was likely 
eliminated from the libraries during the cloning procedures. Previously, 
miR-K12-12-5p was uniquely identified by an approach that relied on computational 
prediction, followed by scoring positive on a custom microarray and then Northern 
blot analysis (Grundhoff et al., 2006b). Because miR-K12-12-3p is a particularly GC 
rich miRNA, it was filtered out as part of the pipeline of microarray analysis utilized 
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in this study; therefore, it was not discovered at that time by Northern blot analysis 
(Grundhoff et al., 2006b). In our present study, miR-K12-12-3p is more abundant or 
at least as abundant as miR-K12-12-5p (Fig. 2.8B), and is fully functional in RISC 
(Fig. 2.8C). This miRNA may be an important driver of the biological activity 
associated with this pre-miRNA. What is the function of miR-K12-12-3p? Currently, 
its function is unknown, but it is notable that the pre-miR-K12-12 and 
pre-miR-K12-10 derivatives are the only viral miRNAs expressed at robust increased 
levels during lytic activation ((Cai et al., 2005), Figs. 2.7, 2.8B). These data are 
consistent with both miRNAs being encoded within the body of the Kaposin 
transcripts that are up-regulated by RTA transactivation during lytic replication 
(Chang et al., 2002; Sadler et al., 1999). These observations point to a likely 
important role during lytic replication or perhaps even a role during the initial times of 
de novo infection (if these miRNAs are somehow packaged within the virion). Future 
studies are required to determine the relevant functions of pre-miR-K12-10 and 
pre-miR-K12-12 derivatives and whether they target viral or host transcripts during 
KSHV infection.  
 
Other KSHV miRNAs did not display robust changes in the relative amplicons that 
were consistent between both the 5p and 3p derivatives (Table 2.2). Northern blot 
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analysis clearly demonstrated that some KSHV miRNAs show slightly increased or 
decreased levels during lytic replication (Fig. 2.7).  Examining host miRNAs that 
were differentially represented in the SOLiD library by Northern blot analysis 
revealed that only half of the miRNAs changed in abundance. This result would be 
expected if relative amplicon number were reflective of actual abundance (data not 
shown). Thus, relative amplicon abundance shows a general trend of congruence but 
not an absolute or linear correlation with actual steady state levels. Whereas some 
host miRNAs change in abundance during lytic replication, it remains to be 
determined whether these changes are caused by a specific viral gene product(s), the 
host innate antiviral response, or rather, represent a bystander effect of the drug 
regimen used to induce the lytic cycle (or the associated stress of lytic replication). 
Because of the possible cloning and sequencing biases that may exist between 
different libraries (Linsen et al., 2009), these combined results may indicate that 
changes in relative amplicon number between different libraries represent only a 
starting point for identifying bona fide changes in miRNA steady state levels. 
 
2.3.2 Systematic cloning of viral and host pre-miRNAs provides insight into 
general miRNA processing   
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Because our experimental strategy profiles a range of RNA size classes, the 5’ ends of 
numerous pre-miRNAs were mapped and cloned. Using the high-quality-filtered 
SOLiD data, 10 of the 12 KSHV pre-miRNAs (Table 2.3, and Fig. 2.7) were 
identified. Additionally, using less stringent filters, the remaining two KSHV 
pre-miRNAs were detected in our library. I also cloned and mapped the 5’ end of 
numerous human host pre-miRNAs. Furthermore, despite the low coverage of our 454 
data, I was able to clone and map the entire transcript (including 5’ and 3’ ends) of a 
few host and viral pre-miRNAs (Fig. 2.13). Several conclusions can be made from 
these data. First, as would be predicted with the microprocessor model of miRNA 
processing (Chendrimada et al., 2005; Denli et al., 2004; Gregory et al., 2004; Seitz 
and Zamore, 2006), the 5’ ends of the pre-miRNAs are almost always co-terminal 
with the 5’ ends of the 5p miRNAs. Furthermore, limited in depth searches into 24 
viral and host pre-miRNAs (Figs. 2.5) did not identify any examples of non-templated 
5’ modifications. Combined, these data strongly suggest that Drosha cleavage, as part 
of the microprocessor complex, determines the final 5’ end of most miRNAs. These 
data argue that cloning and profiling of pre-miRNAs is readily achievable and may be 
of future use for confirmation that candidate miRNAs are indeed derived from 
microprocessor activity (see discussion below regarding KSHV AS miRNAs), or for 
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globally profiling post-transcriptional regulation of specific primary miRNA 
transcripts.  
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Figure 2.13 454 cloned pre-miRNA sequences and predicted secondary 
structures. (A) Cloned pre-miRNAs identified via 454 sequencing in this study. (B) 
The cloned pre-miR-21 and pre-miR-K12-10 predicted secondary structures, with 
derivative miRNAs indicated (Structure determined with Mfold (Mathews et al., 
1999; Zuker, 2003)). Note the two nucleotide 3’ overhangs indicative of Drosha 
processing. 
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2.3.3 A method for identifying regions of a genome enriched for specific 
functional classes of RNAs identifies novel KSHV-encoded small RNAs 
An experimental strategy was developed for identifying genomic regions enriched for 
RNAs of a particular size and functional class (Fig. 2.1A). By plotting the ratio of the 
size class of interest to other sizes in the library (which presumably represents mostly 
degradation fragments of longer transcripts), regions of the genome enriched for a 
novel miRNA (miR-K12-4-AS) were identified (Fig. 2.9). Such an approach may be 
particularly useful when dealing with cells undergoing lytic viral replication, as both 
these discrete transcripts were identified amidst a sea of random degradation 
fragments caused by KSHV lytic activation (Fig. 2.11A). An additional 
low-abundance small RNA, the K12-12 moRNA, may be the first viral moRNA to be 
reported. Thus, the combination of deep sequencing and size- class analysis was 
fruitful for identifying novel KSHV-encoded small RNAs. 
 
One question that arises is whether the K12-12 moRNA is the only KSHV-encoded 
moRNA? Evidence that pre-miRs-K12-4, 5, 6 & 10 also encode moRNAs (Figs. 
2.5C, 2.6D, E, F, J, L), albeit at very low abundance has been observed. This suggests 
that additional viral pre-miRNA loci could be processed into moRNAs at low 
efficiencies (or that cloning biases excluded them from theser libraries). At present, 
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the function of these viral moRNAs is not known, but the seemingly increased 
abundance of the K12-12 moRNA suggests this would be a good starting point for 
future functional studies. 
 
The reasons for over-representation of miR-K-12-4-AS is represented in the library 
compared to the other KSHV AS miRNAs (>100 reads for miR-K-12-4-AS [on par 
with several host-encoded miRNAs] versus less than 10 reads for miR-K-12-2-AS-5p, 
miR-K-12-2-AS-3p, & miR-K-12-8-AS) are unknown. Multiple reasons could explain 
this observation. First, it is possible that only pre-miR-K12-4 can form the proper 
secondary structure to allow efficient miRNA processing when transcribed from the 
opposite strand. The predicted secondary structures of the pre-miRNAs for the KSHV 
AS miRNAs cloned appear to be more plausible as microprocessor substrates than 
KSHV AS  pre-miRNA derivatives not represented in these libraries  (with the 
caveat that predicting microprocessor/Dicer substrates in silico is highly error-prone). 
Furthermore, a novel promoter upstream of miR-K-12-4-AS could allow for 
transcripts that specifically encode this pre-miRNA, but this model is not supported 
by the close proximity of miR-12-4 to its two closest neighbors, miR-K12-5 
(separated by ~85 nts) and miR-K12-3 (separated by ~60 nts). Additionally, studies 
show antisense transcripts exist throughout the KSHV latent miRNA cluster, making 
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this model less likely. Finally, it is possible some of the other KSHV loci might 
encode more abundant AS miRNAs, but cloning biases excluded them from these 
libraries. The transfection studies demonstrating robust expression and activity of the 
K12-4-As miRNA (Figs. 2.9C & D) argue that the relatively low number of 
amplicons observed during lytic infection is most likely due to a low amount of 
transcription of the pri-miRNA. Future experiments will address in detail the 
biogenesis and functions of the KSHV AS miRNAs during lytic infection.  
 
Currently, the function (if any) of all of these low-abundance small KSHV-encoded 
RNAs is unknown. All are represented by numerous amplicons and have discrete ends 
suggestive of specific processing. Due to our ability to isolate intermediates in the 
miRNA biogenesis pathway (pre-miRNAs and 5p and 3p derivatives of the same 
pre-miRNA), I have high confidence that the KSHV AS miRNAs reported here are 
likely derived via specific host miRNA machinery processing. For miR-K-12-4-AS, 
biological activity of this miRNA was demonstrated in a RISC cleavage assay (Fig. 
2.9). The K12-12 moRNA displays the features of other moRNAs (discrete ends 
mapping to the termini of pre-miRNA hairpins), so processing is likely to be similar 
to that of the other known mammalian moRNAs (Langenberger et al., 2009). At 
present, sufficient read depth is unavailable to make the same definitive conclusions 
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about the other putative KSHV moRNAs (K12-4, 5, 6, & 10 moRNAs).  Future 
studies will address the possible functional relevance of these RNAs. 
 
2.3.4 Lytic replication triggers antisense transcription that is detected at discrete 
loci throughout the KSHV genome   
A striking degree of antisense transcription was detected throughout the entire KSHV 
genome during lytic replication (Fig. 2.11A). This observation is perhaps not 
surprising, given the precedence set by lytic infection with other viruses such as 
adenovirus and human cytomegalovirus (Maran and Mathews, 1988; Zhang et al., 
2007). However, this degree of antisense transcription has not been previously 
reported for KSHV. These transcripts are not reflective of a constant degree of 
background transcription that is simply up-regulated during lytic infection, since the 
ratio of antisense transcripts observed (and not just absolute abundance) is 
dramatically higher during lytic replication (data not shown). Such high amounts of 
antisense transcripts have a great potential to form dsRNAs. These observations may 
help to explain why KSHV has evolved numerous countermeasures to deal with the 
cellular interferon immune response that can be activated by dsRNA (Areste and 
Blackbourn, 2009; Bisson et al., 2009; Coscoy, 2007; Lee et al., 2009). In addition, 
these results suggest that the virus must counteract RNA polymerase exclusion and 
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may, in fact, use antisense transcription to regulate viral gene expression. Despite the 
depth of the RNA libraries, and the success of enrichment for specific size classes of 
small RNAs, strong evidence for the existence of abundant viral siRNAs during lytic 
infection was not obtained. A few regions of the genome expressed a high ratio of ~21 
nucleotide RNAs relative to other size classes that would be expected for siRNAs 
(including regions “a”, “b”, and “c” from Fig. 2.2D). Nevertheless, these regions 
mostly encode RNAs in the same orientation as the abundant, annotated, longer 
transcripts derived from these regions (in fact, peak “c” encompasses reads mapping 
in the same direction as PAN, the most abundant KSHV transcript made during 
infection). Thus, our results are not consistent with abundant siRNAs being derived 
from longer antisense transcripts. The great majority of the genome is not enriched for 
small RNAs of the siRNA size class, and in the few regions that do contain 
appropriately-sized RNAs, these RNAs are not of opposing orientations. While the 
possibility that inverted repeat hairpin formation from single-stranded transcripts 
leads to some siRNA generation cannot be excluded, sequence examination of these 
regions failed to demonstrate likely repeat hairpin precursor structures. Therefore, I 
conclude that viral-specific siRNAs during KSHV infection are: (1) not easily cloned, 
(2) of extremely low abundance, or (3) are not made. However, studies of 
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Dicer-knockout cells are needed to address the possibility that KSHV infection 
generates low amounts of siRNAs. 
 
2.4 MATERIALS AND METHODS 
 
2.4.1 Cell Culture and RNA Isolation  
BJAB and BCBL-1 cells were maintained in RPMI 1640 medium supplemented with 
10% FBS, glutamine and β-mercaptoethanol. TREx-RTA BCBL-1 cells were 
maintained in DMEM medium supplemented with 20% FBS, and Hygromycin B (50 
µg/ml). To induce KSHV lytic replication in BCBL-1 cells, tetradecanoyl phorbol 
acetate (TPA, final concentration 20 ng/ml) or sodium butyrate (final concentration 
3mM) was added to the medium 48 h before RNA isolation. To induce KSHV lytic 
replication in TREx-RTA BCBL-1, Doxycycline (2 µg/ml), TPA (20 ng/ml) and 
Ionomycin (500 ng/ml) (referred to as “T.I.D.”) was added to the medium. Induction 
of BCBL-1 cells into the lytic cycle was confirmed by flow cytometric analysis and 
immunofluoresence microscopy staining using antibody that recognizes K8.1, a late 
gene product as the marker. Induction of TREx-RTA BCBL-1 cells into the lytic 
cycle was confirmed by flow cytometric analysis for RTA and K8.1, Northern blot 
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analysis for polyadenylated nuclear RNA, and Western immunoblot analysis for RTA, 
K8.1, and Kaposin B. Total RNA was isolated by using PIG-B solution as described. 
 
2.4.2 Small RNA Library Generation and Computational Analysis of 454 
Sequencing Reads  
Total RNA (400 μg) from un-induced or sodium butyrate-treated BCBL-1 cells were 
separated on an 8% urea denaturing polyacrylamide gel, the ~16-70 nt band was 
excised, crushed, and soaked in 20 ml 0.3 M NaOAc (pH 5.2) overnight at 4
o
C. The 
supernatants were concentrated via centrifugation with the Vivaspin 15R concentrator 
(Sartorius) at 3,000 x g for ~30 minutes at 4
o
C. The RNA was then ethanol 
precipitated by adding 100% ethanol and air-dried. The 3’ ends of the 
size-fractionated RNA were ligated to the linker (5’ 
rAppCTGTAGGCACCATCAAT/3ddC/3’) using T4 RNA ligase (Ambion) at 4oC 
over night. Ligated RNAs were separated from unincorporated linkers on a 15% 
denaturing polyacrylamide gel and extracted as described. The 3’ modified RNAs 
were then treated with tobacco acid pyrophosphatase (Epicentre) to remove the m
7
G 
cap (if present) on the 5’ end, and then ethanol precipitated by adding 100% ethanol. 
An adapter (ACGGAATTCCTCACTGAG, where RNA nucleosides are underlined) 
was ligated to the 5’ ends of RNA using T4 RNA ligase (Ambion) at 4oC overnight. 
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After ethanol precipitation by adding 100% ethanol, the RNA was reverse transcribed 
using the primer ATTGATGGTGCCTACAG in a 40 μl reaction with 200 units of 
SuperScript II reverse transcriptase (Invitrogen) at 42
 o
C for 1 h. The RT product was 
PCR amplified using the forward primer ACGGAATTCCTCACTGAG and the 
reverse primer ATTGATGGTGCCTACAG for 15 cycles and then amplified using 
the forward primer GCCTCCCTCGCGCCATCAGACGGAATTCCTCACTGAG 
and the reverse primer GCCTTGCCAGCCCGCTCAGATTGATGGTGCCTACAG 
for 12 cycles. The PCR samples were then directly analyzed via 454 deep sequencing 
(Roche). 
 
To create a KSHV density map, KSHV genome (NC_009333) was divided into 2000 
bp segments, each overlapping neighboring segments by 1000 bp, to create a Blast 
database. Total sequencing reads were first BLASTed against the KSHV genome and 
then size-filtered into 19-23 nt or non-19-23 nt classes (~16-18-nt & ~25-70-nt) based 
on the number of nucleotide matches. Each subset was then BLASTed against the 
split KSHV genome database. The threshold of E-value for this and subsequent 
BLAST searches was 10
-4
. These parameters will detect sequences with up to two 
nucleotide mismatches.  The number of sequencing reads that matched to each 
binned genomic segment were plotted on a XY scatter chart corresponding to the 
77 
 
location in the genome. To check the relative abundance of KSHV miRNAs, total 
sequencing reads were first BLASTed against the KSHV genome, size-filtered into 
19-23 nt class based on the number of nucleotide matches, and then BLASTed against 
all miRBase annotated KSHV-miRNAs. To check the relative abundance of cellular 
miRNAs, 18-25 nt sequencing reads were BLASTed against the human pre-miRNA 
database acquired from miRBase. Thus, the number of reads listed for a particular 
cellular miRNA (Table 2.1) encompass both the 5p and 3p miRNAs derived from that 
pre-miRNA.  
 
2.4.3 Small RNA Library Generation and Computational Analysis of Sequencing 
Reads for SOLiD 
Total RNA (350 μg) from uninduced or T.I.D.-treated TREx-RTA BCBL-1 cells were 
separated on a 15% urea denaturing polyacrylamide gel, the ~18-25 nt and ~45-75 
size ranges were excised according to the RNA size markers, crushed, and soaked in 
30 ml of 1 M NaCl overnight at 4
o
C. The supernatants were concentrated via 
centrifugation with the Vivaspin 15R concentrator (Sartorius) at 3,000 xg for ~30 
minutes at 4
o
C. The RNA was then ethanol precipitated by adding 100% ethanol, 
pelleted by centrifugation, and air-dried. The four RNA populations were then 
dissolved and converted into cDNA libraries suitable for SOLiD sequencing using a 
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commercially available kit (Small RNA Expression Kit, Ambion, Austin, 
TX).  Briefly, degenerate double-stranded sticky-end adaptors were ligated to the 
single-stranded RNA, with 5'- and 3'-specific adaptors, distinguished by sequence, so 
RNA sequence orientation could be determined upon sequencing.  The RNA was 
reverse transcribed and treated with RNase H and fragments of the appropriate length 
were selected by PAGE. An additional barcode sequence was appended to the 3' end of 
these single-stranded cDNA via PCR of these RNase-H treated samples with primers 
complementary to the 5' and 3' adaptors. A final agarose gel purification was performed 
to isolate full length library product.  During library construction, the location of gel 
excisions was adjusted to account for the 
the longer 45-70 nt population. ABI SOLiD sequencing was performed according to 
the manufacturer's instructions on the SOLiD version 3.0 instrument and associated 
protocols. Quantitative PCR was used to measure each barcoded cDNA library, which 
were then pooled in equimolar amounts.  Emulsion PCR was performed on this pool 
according to manufacturer's instructions to generate beads ready for deposition and 
sequencing on the ABI SOLiD.  The five base barcodes of each sequencing bead were 
read first, followed by thirty-five bases of the corresponding cDNA 
sequence.  Software provided by ABI and custom PERL scripts were used to separate 
the reads based on their barcode sequences and discard any reads with eight or more 
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bases with a quality value of less than 8, resulting in the number of reads shown in 
Table 2.2. The reads for each sample were then processed by the small RNA analysis 
pipeline (v0.5) available at solidsoftwaretools.org.  Briefly, this pipeline: a) removed 
reads matching human ribosomal or tRNA and reads containing no template, b) 
matched each read to the known human and KS microRNA precursor regions in the 
human and KSHV genomes (NCBI36 and EMBL U75698.1, respectively, as annotated 
by the Sanger miRBase version 13.0, gff-version 2) wherein the match starts with a 
short seed and progressively maps until finding adaptor sequence, and c) matched all 
remaining reads to the human and KS genomes (NCBI36 and NC_009333.1, 
respectively).  Reads not falling within the expected size ranges (18-24 nt for small 
RNA, >30 nt for large RNA) were removed from further analysis to minimize artifacts 
from degradation, low sequence quality, or inaccurate mapping.  Custom PERL scripts 
were then used to extract start site and length information for each read and to extract 
mature miRNA counts from the mappings to miRBase precursors. 
 
Read Size Class Analysis. Two size classes were defined as small (19-23 nt) from 
short fractions and large (45-75 nt) from long fractions. The number of mapped reads 
of each size class was summed in a sliding window of size W nucleotides across the 
genome in 1 nucleotide increments. Windows with less than 20 short reads or less 
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than 1 long read were discarded. The value for each window was then computed as 
the number of small reads divided by the number of large reads. 
 
2.4.4 Western Immunoblot Analysis 
Cells were lysed with RIPA buffer (0.1% SDS, 1% Triton X-100, 1% deoxycholate, 5 
mM EDTA, 150 mM NaCl, and 10 mM Tris, pH7.2). Total lysate (50µg) was 
separated on 12% SDS-polyacrylamide gels, and transferred to PVDF membranes 
(Millipore). Primary antibodies used in this paper are rabbit anti-RTA antibody (a gift 
from Don Ganem, UCSF), rabbit anti-Kaposin B antibody (a gift from Craig 
McCormick, UCSF) and mouse anti-ORF K8.1 A/B antibody (Advanced 
Biotechnologies Inc.). Blots were probed with a 1:1000 of primary antibody in 5% 
dehydrated milk in Tris-Buffered Saline (TBS) and 1:3000 dilution for the 
HRP-conjugated secondary antibodies (Invitrogen). Blots were washed in TBS 
multiple times, incubated with chemilumiescent substrate (SuperSignal West Pico, 
Thermo Scientific, Rockford IL) according to the manufacturer’s protocol, and 
exposed to autoradiography film for visualization of bands. 
 
2.4.5 Northern Blot Analysis 
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Small RNA Northern blot analysis was performed as described (Grundhoff et al., 
2006b). The probe sequences used in this paper are listed in Table 2.4. Northern blot 
analysis for Polyadenylated Noncoding RNA (PAN) was conducted using total RNA 
that was separated on a 1% agarose formaldehyde gel and then transferred using 
Whatman TurboBlotter Rapid Downward Transfer Systems. Probes and hybridization 
for PAN were conducted via an identical strategy used for the small RNA Northern 
blot analysis (see Table 2.4). 
 
2.4.6 Flow Cytometry 
Cells were collected 48 hours after mock treatment, or treatment with lytic 
replication-inducing drugs. Cell were washed with cold Phosphate buffered saline 
(PBS) buffer, fixed and permeabilized with ice cold 1:1 acetone/methanol for 5 
minutes, and then blocked with 1% BSA containing PBS solution for 10 minutes. 
Primary antibodies against RTA and K8.1 were added to the solution and incubated 
for one hour at room temperature. Cells were washed with PBS buffer three times and 
stained with Alexa Fluor 488-conjugated secondary antibodies (Invitrogen). The 
working concentration of primary and secondary antibodies was a 1:1000 dilution. 
Stained samples were analyzed by flow cytometry with a FACSCalibur flow 
cytometer. The data was analyzed with Cell Pro Software (Becton Dickinson, Bedford, 
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MA). Dead cells, as determined from aberrant forward / side scatter, were eliminated 
from the analysis.  
 
2.4.7 pre-miRNA Structure Prediction 
Secondary structures of pre-miRNAs were predicted by the Mfold RNA folding 
prediction web server (Mathews et al., 1999; Zuker, 2003).  
 
2.4.8 Vector Construction, Transfection, and Luciferase Assays 
The expression vectors pcDNA3.1-pre-miR-K12-10, pcDNA3.1-pre-miR-K12-12, 
pcDNA3.1-pre-miR-K12- 4 and pcDNA3.1-pre-miR-K12-4-AS expression vectors 
were made by cloning a ~200 bp fragment with the entire pre-miRNA hairpin and 
flanking regions into the pcDNA3.1 vector. The miR-K12-12-5p reporter, 
miR-K12-12-3p reporter and miR-K12-4-AS-3p reporter were made by cloning 4 
copies of the complementary sequences of the miRNAs into pcDNA3.1dsRluc vector 
(Seo et al., 2008). The seed-region-mutated reporters contain engineered point 
mutations from the second nucleotide to the sixth nucleotide complementary to the 5’ 
end of the relevant miRNA. The primers used for cloning are listed in Table 2.4. All 
sequences were confirmed by Sanger sequencing.  Cells (293T) were plated in 12 
well plates and transfected with Lipofectamine 2000 reagent (Invitrogen). Cells were 
83 
 
transfected with miRNA expression vectors along with the reporter. 
pcDNA3.1Luc2CP vector was also co-transfected as a control for transfection 
efficiency. Cells were collected 48 hours after transfection and analyzed with the 
Dual-Glo Luciferase Assay System (Promega) according to the manufacturer’s 
instructions. The luciferase assays were analyzed on a Lumioskan Ascent 
luminometer (Thermo Electronic Cooperation). Results for the miRNA reporters are 
presented with the Renilla luciferase levels normalized by firefly luciferase levels. 
 
2.4.9 Directional RT-PCR 
The total RNA from BJAB or induced TREx-RTA BCBL-1 cells were treated with 
Turbo DNase (Ambion) according to the manufacturer’s instructions. DNase-treated 
RNA (300 ng) was reverse transcribed to cDNA with avian myeloblastosis virus 
(AMV) reverse transcriptase (Finnzymes) using specific RT primers at 64
o
C for 50 
minutes and 60
 o
C for 10 minutes. One twentieth of the RT product was used for PCR 
amplification using specific primers and analyzed by agarose gel electrophoresis. A 
control lacking RT was included to confirm that the bands detected were not due to 
contaminating DNA.  All the RT primers and PCR primers are listed in Table 2.4. 
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Chapter 3: Direct Regulation of Kaposin B Expression by The Microprocessor  
 
3.1 INTRODUCTION 
Understanding how viruses regulate their own gene expression is an active area of 
research with relevance to numerous diseases. Viruses with RNA genomes typically 
rely on RNA-binding proteins and cis transcript elements to control gene expression 
(Liu et al., 2009). For DNA viral gene regulation, host and viral transcription and 
chromatin-associated factors are best characterized (Lieberman, 2008; Yaniv, 2009), 
although the role of cis RNA regulatory elements is understudied. Recently, some 
DNA viruses have been shown to encode trans regulatory small RNAs called 
microRNAs (miRNAs) that bind to mRNAs and negatively regulate host or viral gene 
expression. Over 200 miRNAs have been described from viruses with DNA genomes 
that undergo a nuclear replication cycle (reviewed in (Boss and Renne, 2010; Skalsky 
and Cullen, 2010; Sullivan, 2008)). Like host-encoded miRNAs, the functions of the 
majority of viral miRNAs are unknown. Few viral miRNAs are homologous with host 
miRNAs, which implies that most viral miRNAs will either regulate viral transcripts 
or host transcripts via unique binding sites (Grundhoff and Sullivan, 2011), or 
possibly that viral miRNAs may have novel, as yet unknown functions.  
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Viruses utilize the host machinery for miRNA biogenesis, including the nuclear 
microprocessor complex containing the double-stranded RNA (dsRNA) endonuclease 
Drosha and its binding partner DGCR8. Drosha cleaves the primary miRNA transcript 
to liberate a hairpin secondary structure called a pre-miRNA (reviewed in (Kim, 
2005)). The pre-miRNA is then exported to the cytoplasm and further processed into 
the functioning miRNA (Fig. 3.1A). Drosha cleavage also mediates direct cis 
regulation of DGCR8 mRNA levels and thus, serves as a mechanism to autoregulate 
its own miRNA biogenesis activity (Han et al., 2009). In addition, it is likely that 
some additional mRNAs (containing pre-miRNA-like structures) are also directly 
regulated by Drosha-mediated cleavage, but these transcripts have not been 
well-characterized and no functional significance has been attributed to this possible 
mode of regulation (Chong et al., 2010; Shenoy and Blelloch, 2009). It is unknown 
whether viral transcripts are regulated via a similar mechanism, but at least five 
different viruses (Kaposi’s sarcoma-associated herpesvirus (KSHV), murine 
cytomegalovirus (MCMV), Epstein Barr Virus (EBV) and Marek’s disease viruses 1 
& 2 (MDVs 1 & 2)) encode transcripts containing pre-miRNA structures located 
within an mRNA (Boss and Renne, 2010). This suggests Drosha-mediated cis 
regulation of gene expression may be a common regulatory strategy amongst 
divergent herpesviruses. 
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KSHV is a lymphotropic virus associated with hyperproliferative B cell disorders and 
Kaposi’s Sarcoma (KS), a highly vascularized lesion composed mainly of endothelial 
cells, that afflicts mostly immunocompromised patients (Ganem, 2007). Like all 
herpesviruses, KSHV has both a “latent” phase of infection whereby only a few viral 
transcripts are expressed and a “lytic” phase, whereby the remaining (~85) viral 
mRNA transcripts are expressed culminating in lysis of the infected cell and the 
release of progeny virions (Speck and Ganem, 2010). Although most KSHV gene 
products are classified strictly as either latent or lytic proteins, Kaposin B (KapB) is 
atypical in that it is constantly transcribed at a low level during latency, but is also 
dramatically induced upon lytic replication (Sadler et al., 1999). A complete 
understanding of this induction is lacking, part of this results from KapB being driven 
by two different KapB promoters: one constitutively active in latency and one that is 
activated during lytic replication by a viral “master lytic switch” transcription factor, 
RTA (Fig. S1) (Chang et al., 2002; Li et al., 2002; Sadler et al., 1999). Exogenous 
expression of KapB has been shown to have cytotoxic effects and also to induce the 
p38 stress kinase signaling pathway (McCormick and Ganem, 2005; Sadler et al., 
1999). Thus, proper regulation of the kinetics and abundance of KapB expression are 
likely important to the fitness of the virus.  
 
87 
 
Compared to other KSHV transcripts, KapB is unique since its 3’ untranslated region 
(UTR) contains two pre-miRNAs that give rise to miRs-K12-10 & K12-12 (Sullivan 
and Cullen, 2009). In this work, I tested whether these pre-miRNAs could play a 
negative cis regulatory role on KapB transcripts. The results demonstrate that 
Drosha-mediated cleavage of these pre-miRNAs negatively regulates KapB protein 
levels in latently infected cells. Furthermore, this mode of regulation is inhibited 
during lytic replication. Thus, in addition to transcriptional regulation, decreased 
Drosha activity contributes to the differential levels of KapB that are made during the 
lytic and latent phases of infection. Therefore, this work expands the known functions 
of Drosha, and implies that viruses can utilize the miRNA biogenesis machinery for 
novel purposes in optimizing gene expression in lytic versus latent replication. 
 
3.2 RESULTS 
 
3.2.1 The pre-miRNAs encoding miRs-K12-10 and K12-12 are negative cis 
regulatory elements 
For transcripts that serve the dual role as both mRNA and primary miRNA 
(pri-miRNA), cleavage by Drosha is an irreversible action that should prevent nuclear 
export and subsequent translation of the cleaved mRNA. Thus, such transcripts face a 
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binary decision of whether to become mRNAs or miRNAs (Fig. 3.1A). Therefore, 
hypothesized that the pre-miRNAs encoding miRs-K12-10 and K12-12, within the 
KapB 3’ UTR, function as negative cis regulatory elements. Heterologous expression 
constructs were engineered in which pre-miRs-K12-10, K12-12, or both were mutated 
to disrupt the characteristic secondary structure of a pre-miRNA.  To minimize the 
chances of artifactual results if one of the mutants caused unintended, 
pre-miRNA-independent stabilizing effects, two different small internal deletion 
mutants were engineered for each pre-miRNA hairpin (Fig. 3.1B). Each mutant 
strategy (deleting either the sequence corresponding to the miRNA strand or the 
passenger star strand) was employed individually or in combination. These constructs 
were transfected into HEK293T cells and immunoblot analysis was conducted on 
total protein lysates. All mutant constructs resulted in increased expression of KapB 
protein, with pre-miR-K12-10 playing a more readily-detectable regulatory role than 
pre-miR-12-12 (Fig. 3.1D). Deleting both pre-miRNAs (DD-1 or DD2) resulted in the 
greatest increase in KapB levels, suggesting both pre-miRNAs contribute to 
negatively regulate KapB transcripts. To ensure that the derivative miRNAs from 
pre-miRs-K12-10 and K12-12 could not regulate coding portions of the KapB 
transcript in trans, reporter constructs were generated in which the KapB coding 
region was replaced with luciferase. Luciferase assays were conducted on protein 
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lysates harvested from cells transfected with these reporters. These results were 
significant, showing identical trends to that observed for KapB protein (Fig. 3.1E). To 
further rule out the possibility of trans regulation by these miRNAs, co-transfection of 
plasmids expressing miRs-K12-10 and K12-12 had no effect on KapB protein levels 
(Fig. 3.3). Combined, these results demonstrate that both pre-miRs-K12-10 and 
K12-12 are negative cis regulatory elements for KapB transcripts, with 
pre-miR-K12-10 playing a greater role than pre-miR-K12-12. 
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Figure 3.1 Some KSHV pre-miRNAs mediate cis regulation of KapB transcripts 
(A) Diagram of binary decision hypothesis. (B) Diagram of the KapB transcript. The 3’ 
UTR of KapB contains pre-miRs-K12-10 and K12-12.  The distance (in nucleotides) 
from the polyadenylation cleavage site for each pre-miRNA is indicated for constructs 
expressing KapB. The shaded regions denote the deleted sequences of each 
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pre-miRNA possessed by the D-1 and D-2 series mutants. Note, the DD-1 mutant 
refers to a double mutant of the D-1 sequences in both pre-miRs-K12-10 and K12-12, 
and DD-2 refers to a double mutant of both D-2 sequences in pre-miRs-K12-10 and 
K12-12. Unless otherwise noted, the “DD” nomenclature refers to the DD-1 double 
mutant.  (C) Immunoblot analysis demonstrates that KapB expression increases when 
the pre-miRNA structures are mutated. HEK293T cells were transfected with various 
constructs and immunoblot analysis performed with indicated antibody.  β-Actin is 
shown as a load control. (D) Luciferase assay confirms regulatory roles of pre-miRNA 
structures. Wild type or mutant KapB 3’UTR sequences were cloned downstream of 
the firefly Luciferase ORF, and these vectors were transfected into HEK293T cells 
along with a Renilla luciferase expression vector. The cells were harvested 48 hours 
after transfection, and assayed for luciferase activity. The data is shown as firefly 
normalized to Renilla luciferase activity. 
 
 
 
 
 
 
92 
 
 
Figure 3.2 Transcript map of KapB mRNA and pre-miRs-K12-10 and 
miR-K12-12. The two promoters can drive KapB mRNA transcription. One promoter 
is lytic specific and under the control of KSHV lytic master regulator RTA. These 
results with KapB predict other transcripts from the Kaposin locus, such as KapA or 
KapC will contain the pre-miRs-K12-10 &12 and would therefore also likely be 
subject to the same mode of direct Drosha regulation observed for KapB transcripts. 
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Figure 3.3 miRs-K12-10 and K12-12 do not mediate trans-regulation of KapB 
levels. To control for any possible trans-mediated effects of the derivative KapB 
mRNA miRNAs, KapB-FL and KapB-DD expression vectors were co-transfected into 
HEK-293T cells with an empty vector control (pcDNA3.1) or with a vector expressing 
miRs-K12-10 and K12-12. Two days after transfection, cells were harvested and 
immunoblot analysis (A) or Northern blot analysis (B) was conducted. No differences 
in KapB expression levels (derived from the KapB-DD construct) were observed in the 
presence or absence of miRs-K12-10 & 12. For comparison, KapB protein and 
miRNAs derived from the intact 3’UTR (KapB-FL) are shown in the left-most lanes. 
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3.2.2 Drosha mediates cis regulation of KapB transcripts 
Having demonstrated that the pre-miRNAs in the KapB 3’ UTR are negative 
regulatory elements, I next tested whether Drosha cleavage plays a role in this 
regulation. Co-transfection of plasmids expressing Drosha and DGCR8 along with the 
various KapB 3’ UTR mutants resulted in decreased expression of KapB protein from 
all constructs tested except KapB-DD that has deletions of both the K12-10 and 
K12-12 pre-miRNAs (Fig. 3.4A). Interestingly, the pre-miR-K12-10 deletion was less 
susceptible to Drosha-mediated cleavage than the pre-miR-K12-12 mutant, consistent 
with pre-miR-K12-10 being the preferred substrate for Drosha (Fig. 3.4A, right 
panel). To directly assay for Drosha-mediated cleavage, RNA was harvested from 
these experimental treatments and Northern blot analysis was conducted using probes 
designed to recognize full-length and 3’ cleavage fragments of KapB mRNA. This 
analysis showed a band migrating at the expected position for full-length KapB 
mRNA, as well as bands migrating at the expected positions for the two 3’ fragments 
generated by Drosha-mediated cleavage of either pre-miRs-K12-10 or K12-12 (Figs. 
3.1B, 3.4B). Importantly, overexpression of Drosha/DGCR8 resulted in enhanced 
generation of the expected cleavage fragment for each construct, except KapB-DD, 
the double mutant lacking pre-miRNAs. (Note that the mRNA/fragment ratio 
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decreases for all constructs except KapB-DD in the presence of exogenous 
Drosha/DGCR8 (Fig. 3.4B)).  
 
I next examined whether Drosha activity can regulate KapB expression in infected 
cells. BCBLs are primary effusion lymphoma (PEL) cells that are predominantly 
latently infected with KSHV (Renne et al., 1996). A previously characterized 
Drosha-specific siRNA (Han et al., 2009) was used to knockdown Drosha levels in 
TREx-RTA BCBL-1 cells. Knockdown of Drosha protein was observed along with a 
concurrent increase in KapB protein levels (Fig. 3.4C). A reciprocal experiment, in 
which Drosha and DGCR8 proteins were overexpressed, resulted in the opposite 
phenotype (Fig. 3.4D). Importantly, control experiments show that reduction of 
Drosha levels does not ectopically induce RTA or surface K8.1 expression (hallmarks 
of lytic replication), thereby ruling out indirect RTA-mediated induction of KapB 
(Fig. 3.5). Thus, Drosha-mediated cleavage directly regulates KapB transcripts. This 
regulation occurs during bona fide infection at physiological levels of Drosha.  
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Figure 3.4 Drosha regulates KapB expression through processing of pre-miRNA 
cis elements. (A) Immunoblot analysis demonstrates that overexpression of Drosha 
and DGCR8 leads to decreased KapB expression. Various KapB expression vectors 
were co-transfected into HEK293T cells along with Drosha and DGCR8 expression 
vectors (see legend for Fig. 3.1 C, D for description of KapB mutant vectors). After 48 
hours, cells were harvested for immunoblot analysis. Note, at this exposure level, only 
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over-expressed and not endogenous Drosha levels are detectable. β-Actin levels are 
shown as a loading control. (B) Northern blot analysis demonstrates that 
overexpression of Drosha and DGCR8 leads to accumulation of cleaved fragments 
from KapB mRNA for those constructs that retain one or more pre-miRNAs in the 
3’UTR. Transfections were conducted as described in Fig. 3.4A. A ~220 nt 
radiolabeled probe complementary to the 3’ end of the KapB transcript (diagrammed at 
bottom of panel B) was used to detect full-length KapB mRNA or the cleaved 
products. The calculated ratio of full-length KapB mRNA to cleavage fragments is 
shown below each lane. Note that the fastest migrating cleavage fragment band 
(indicated with gray arrow) could represent the cleavage product of either 
pre-miR-K12-12 alone, or cleavage of both pre-miR-K12-12 and pre-miR-K12-10. The 
black arrow indicates the fragment generated by cleavage of pre-miR-K12-10. (C, D) 
Drosha levels regulate KapB expression in KSHV- infected cells. (C) Decreasing 
Drosha levels increases KapB expression. Drosha siRNAs were transfected into 
TREx-RTA BCBL-1 cells and immunoblot analysis was performed. (D) Increasing 
Drosha/DGCR8 levels decreases KapB expression. Drosha and DGCR8 expression 
vectors were co-transfected into TREx-RTA BCBL-1 cells and immunoblot analysis 
was performed. 
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Figure 3.5 Knockdown of Drosha does not induce markers of lytic replication. (A) 
TREx-RTA BCBL-1 cells were transfected with siRNAs to knock down Drosha or 
DGCR8 levels and immunoblot analysis shows that no induction of RTA is observed 
by this treatment. Chemically-mediated lytic induction confirms expected increase in 
RTA levels. Notably, knockdown of DGCR8 a binding partner of Drosha results in 
increased KapB protein levels. DGCR8 levels also serve as a positive control for 
knockdown of Drosha since DGCR8 mRNA is a direct substrate of Drosha (Han et al., 
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2004). KapB-L indicates a light exposure, and KapB-D indicates a darker exposure of 
the same KapB immunoblot. (B) Flow ctyometric analysis shows no increase in surface 
levels of KSHV lytic protein K8.1 when Drosha levels are knocked down. Chemical 
induction of lytic replication confirms expected increase in surface levels of the K8.1 
lytic marker. 
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3.2.3 Physiological consequences of direct Drosha-mediated regulation of KapB 
transcripts  
Since Drosha can directly regulate the levels of KapB, I next addressed whether 
Drosha-mediated cis regulation can affect the functionality of KapB. The original 
report describing KapB noted that it was difficult to generate cell lines stably 
expressing KapB, likely due to cytotoxicity associated with high levels of expression 
of this protein (Sadler et al., 1999). Therefore, a quantitative short-term cytotoxicity 
assay was developed. Transfection of increasing amounts of plasmid encoding KapB 
into TREx-RTA BCBL-1 cells resulted in an increasing proportion of dying cells as 
evidenced by cells positive for propidium iodide and/or Annexin V staining (Fig. 
3.6A). Next, cells were transfected with constructs expressing KapB with either the 
full length 3’ UTR (KapB-FL) or a double deletion mutant 3’ UTR that is not cleaved 
by Drosha (KapB-DD). Transfection of control vector induced a baseline toxicity in 
the cells, while as expected, transfection of KapB-FL increased cytotoxicity (Fig. 
3.6B & C). Importantly, transfection of KapB-DD induced the highest level of dying 
cells, consistent with the increased levels of KapB produced from this construct. 
Notably, the degree of difference in KapB steady state protein levels observed 
between the KapB-FL and KapB-DD constructs in these transient transfection assays 
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is comparable to the differences in endogenous KapB levels observed in our Drosha 
knockdown studies (Fig. 3.4C).  
 
To ensure that the observed increased cytotoxicity in the absence of the KapB 3’ UTR 
pre-miRNAs was not due to trans targeting via the derivative miRNAs, identical 
experiments shown in Fig. 3.6B & C were conducted, except that a vector expressing 
miRs-K12-10 and K12-12 was also included. Co-transfection of the vector expressing 
miRs-K12-10 and K12-12 along with the Kap-DD construct resulted in levels of 
miRNA expression approximately equal to those expressed from the KapB-FL vector 
(Fig. 3.6E). However, this did not alter the increased KapB protein levels nor the 
increased cytotoxicity phenotype associated with the KapB-DD construct (Fig. 3.6D 
& F). Combined, these data demonstrate that the differences in KapB protein levels 
associated with Drosha-mediated regulation are sufficient to alter the biological 
activity of KapB.  
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Figure 3.6 Direct Drosha-mediated regulation of KapB transcripts can affect 
biological activity of KapB protein. (A) KapB triggers cell death in a dose-dependent 
manner. Increasing amounts of the construct expressing the double mutant KapB-DD 
(lacking both pre-miRs-K12-10 and K12-12) were transfected to TREx –RTA BCBL-1 
cells. The total amount of DNA transfected was held constant by including differing 
amounts of the empty vector (pCR3.1). After 48 hours, cells were harvested, and 
stained with Alexa Fluor 488 labeled Annexin V and propidium iodide. The samples 
were then analyzed by a FACS. Dying cells score within the lower right and upper left 
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and right quadrants. (B, C) Transfection of the KapB construct lacking pre-miRNA cis 
elements results in increased cytotoxicity. TREx –RTA BCBL-1 cells were transfected 
as described in Fig. 3.6A, or with a vector expressing KapB and with an in tact 
full-length 3’ UTR (KapB-FL), or with a control empty vector (Vector). (C) Plotting 
the data of three independent replicates from the experiments shown in Fig. 3.6C. (D, 
E, F) The differences in cytotoxicity observed are not due to the derivative miRNAs 
miRs-K12-10 or K12-12. Empty vector, KapB-FL vector, or the KapB-DD vector were 
transfected into TREx –RTA BCBL-1 cells along with vectors expressing miRs-k12-10 
and miR-K12-12 to screen for any trans-effects of derivative miRNAs in this 
cytotoxicity assay. (E) Northern blot analysis demonstrates that miRs-K12-10 and 
miR-K12-12 are expressed to comparable levels whether derived from KapB-FL or 
from a separate miRNA-expression construct co-expressed with KapB-DD. RNA was 
harvested from TREx–RTA BCBL-1 cells transfected as described in Fig. 3.6D. (F) 
Immunoblot analysis from samples in Fig. 3.6D/E demonstrates differences in KapB 
protein expression levels between cells transfected with KapB-FL or KapB-DD persists 
even in the presence of trans-expressed miRs-K12-10 and K12-12. For both panels D 
and E, “V” labels the control lane that was co-transfected with parental vector instead 
of a KapB expression vector. 
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3.2.4 Drosha-mediated regulation is inhibited during lytic infection  
During the course of this study, greater induction of the KapB protein than the 
miRNAs miRs-K12-10 & 12 was observed during lytic replication. Thus Drosha was 
hypothesized to have decreased steady state levels and/or decreased activity during 
lytic replication. To test this hypothesis, I first conducted immunoblot analysis 
comparing Drosha protein levels during latency to several different times post-lytic 
induction. This analysis showed a decrease in Drosha steady state levels beginning as 
early as twelve hours post-induction, with the effect being dramatically enhanced 
during the course of RTA-responsive lytic infection (Fig. 3.7A). Concurrently, an 
increasing amount of KapB protein was observed, which was expected due to the 
increased transcription of the lytic promoter.  
 
These results also suggest that increased KapB is partly attributable to decreased 
Drosha-mediated cleavage. To test whether the lytic-induced decrease in Drosha 
levels results in differential cleavage of the KapB mRNA, Northern blot analysis was 
performed for the KapB full length mRNA, as well as the KapB mRNA 3’ fragments 
that result from Drosha-mediated cleavage. This analysis showed that, as expected 
from increased lytic transcription, both the full-length mRNA and Drosha cleavage 
fragments increased during the course of lytic infection. However, the kinetics of 
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accumulation of these Drosha substrates and products were different. During latency 
and at early times post-lytic induction (up to twelve hours), the ratio of full-length 
KapB mRNA:cleaved KapB fragment RNAs remains constant. Then, starting at 
approximately 24 hours post-lytic induction, the ratio dramatically increases until late 
times of lytic replication (greater than 48 hours post-induction) (Fig. 3.7B & C). The 
kinetics of induction of miRs-K12-10 and K12-12 more closely match the KapB 
mRNA cleavage fragments, which might be expected since all are derivatives of 
Drosha cleavage products. Interestingly, the ratio of the faster-migrating KapB 
mRNA cleavage fragment (corresponding to cleavage of pre-miR-K12 or both 
pre-miR-K12-12 and pre-miR-K12-10) to the slower-migrating cleavage fragment 
(corresponding to cleavage of pre-miR-K12-10 alone) inverts during the course of 
infection, consistent with limiting Drosha activity and pre-miR-K12-10 being the 
preferred Drosha substrate (Fig. 3.7B & D). Combined, these data support a greater 
role for Drosha in regulating KapB mRNA levels during latent infection and at early 
times post-lytic induction. Therefore, several lines of evidence strongly suggest that 
Drosha activity becomes limiting during the course of lytic replication. These include 
(1) Decreasing Drosha protein levels, (2) Altered ratios of Drosha substrate and 
products, and (3) Increasing proportions of products from Drosha-favored substrates 
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over less-efficiently cleaved substrates. Thus, Drosha-mediated cleavage differentially 
regulates KapB expression in latent versus lytic infection.  
 
Next, the observed differences in Drosha levels were tested relative to viral gene 
products and lytic replication. To control for possible off-target effects from the drug 
regimen used to induce lytic replication in the latently-infected PEL B cells, Drosha 
protein levels were measured in the presence of an shRNA specific to RTA (the 
master lytic switch transcription factor). Transfection of TREx-RTA BCBL-1 cells 
with the RTA shRNA (but not an irrelevant control shRNA) prior to induction of lytic 
replication, resulted in decreased levels of RTA (Fig. 3.7D). In these cells, a marked 
increase in Drosha levels was observed, implying that viral gene products and lytic 
replication are responsible for the reduced Drosha levels observed. The magnitude of 
these results is likely an underestimate, since even with shRNA-mediated knockdown 
of RTA, a noticeable, albeit less robust increase in RTA levels is still observed. To 
determine if lytic replication decreases Drosha levels in a different model of infection 
(Grossmann et al., 2006), primary human umbilical vein endothelial cells (HUVECs) 
were utilized. Although B cells are a prominent reservoir of latent infection for 
KSHV, KS lesions are predominantly composed of endothelial cells. De novo latent 
infection of HUVECs did not alter Drosha levels (Fig. 3.7E). However, co-infection 
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of KSHV with an adenovirus RTA expression vector (adRTA), resulted in induction 
of lytic replication and a decrease in Drosha levels (Fig. 3.7E). Importantly, infection 
with adRTA alone, or co-infection of KSHV and control adenovirus expressing the 
irrelevant viral protein vGPCR, had little effect on Drosha levels. These results clearly 
show that KSHV lytic infection of PEL B cells or endothelial cells results in 
decreased Drosha levels.  
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Figure 3.7 Lytic infection decreases Drosha levels resulting in decreased cis 
regulation of KapB transcripts. (A) KSHV lytic infection leads to down-regulation of 
Drosha protein levels in TREx–RTA BCBL-1 cells. HPI = “hours post induction” of 
lytic replication. (B, C) Northern blot analysis demonstrates differences in the kinetics 
of accumulation of Drosha substrates and products in TREx–RTA BCBL-1 cells at 
various times post induction of lytic replication. (B) Full length KapB mRNA shows 
robust increases starting at 24 HPI, whereas Drosha substrates (cleaved fragments and 
miRs-K12-10 and K12-12) start accumulating as early as 12 HPI, but the degree of 
increase slows as Drosha levels diminish. The black arrow indicates the fragment 
generated by cleavage of pre-miR-K12-10. The gray arrow indicates the products of 
transcripts cleaved at either pre-miR-K12-12 alone, or at both pre-miR-K12-12 and 
pre-miR-K12-10 (See Fig. 3.2 for a detailed diagram). (C) The ratio of full-length 
KapB mRNA:KapB mRNA cleavage fragments changes during the course of lytic 
infection demonstrating Drosha-mediated cleavage plays a greater regulatory role of 
KapB expression levels during latent infection. A representative plot of multiple 
independent experiments (similar to Fig. 3.7B) shows the ratio of full-length KapB 
mRNA: KapB mRNA cleavage fragments. (D) The ratio of fast:slow migrating 
cleavage fragments inverts during the course of lytic infection demonstrating decreased 
Drosha activity and that pre-miR-K12-10 is a preferred Drosha substrate over 
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pre-miR-K12-12. A representative plot of multiple independent experiments (similar to 
Fig. 3.7B) (E, F) is shown. Independent models of KSHV lytic replication decrease 
Drosha levels. (E) To ensure lytic replication (and not the drug regimen used to induce 
primary effusion lymphoma (PEL) B cells into lytic replication) is responsible for the 
decreases in Drosha levels, lytic-inducing drugs were added to TREx–RTA BCBL-1 
cells transfected with an shRNA that knocks down RTA (the lytic switch protein whose 
expression is necessary and sufficient for lytic induction). Immunoblot analysis shows 
that partial knockdown of RTA results in increased Drosha levels. β-Actin levels are 
shown as a loading control. (F) KSHV de novo lytic infection of primary endothelial 
cells (HUVECs) results in decreased Drosha levels. “+” indicates KSHV virus was 
added. Super-infection with an RTA-expressing adenoviral vector was utilized to 
induce lytic replication. An adenoviral vector expressing the viral protein vGPCR 
(which is not sufficient to induce lytic replication) was included as a negative control. 
Only co-infection with KSHV and the Ad-RTA vector negatively regulates Drosha 
levels. Double infection with Ad-RTA and KSHV results in increased levels of RTA 
over AD-RTA infection alone. This is consistent with the previously characterized 
RTA autoregulation of its own promoter.  
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3.3 DISCUSSION 
 
Determining how viruses control their own gene expression is key to understanding 
the pathogenesis associated with infection. Previously, the only known biological 
activities of Drosha involved the biogenesis of miRNAs (either directly converting 
pre-miRNAs to miRNAs, or indirectly by Drosha regulating the mRNA levels of 
DGCR8). This work extends the biological activities of Drosha to regulation of viral 
gene expression. At the same time, the results suggest previously unanticipated cis 
regulatory functions are likely for some of the over 200 viral pre-miRNAs that have 
been discovered. Deciphering the functions of viral miRNAs is currently an area of 
intense interest from multiple laboratories. Increasing evidence suggests that the 
functions of some viral miRNAs include the trans targeting of host or viral mRNAs 
(Grundhoff and Sullivan, 2011). However, other functions remain possible, especially 
given that the majority of viral miRNAs have no known function. Here I demonstrate 
that KSHV pre-miRNAs, pre-miRs-K12-10 and K12-12, are negative regulatory 
elements that function in cis within the KapB mRNAs. These results in no way rule 
out additional functions for the derivative miRNAs miRs-K12-10 and K12-12. (In 
fact, miR-K12-10 has recently been shown to target the host transcript TWEAKR 
(Abend et al., 2010)). This work shows that Drosha directly cleaves KapB transcripts, 
112 
 
resulting in decreased KapB protein levels in latently infected cells. Interestingly, this 
regulation decreases during the course of lytic infection concomitant with a decrease 
in Drosha protein steady state levels.  
 
What mechanism accounts for the decreased Drosha levels that are observed during 
lytic infection? The mRNA steady state levels of Drosha decrease during lytic 
replication, whereas the half-life of Drosha protein is ~4 hours in latently or 
lytically-infected cells (Fig. 3.8). Given that KSHV is known to induce host shutoff 
by causing degradation of host mRNAs (Glaunsinger and Ganem, 2004b), 
viral-mediated global turnover of mRNAs combined with the relatively short half-life 
of Drosha protein likely accounts for at least some of the turnover observed. In 
support of this, I show that knockdown of SOX, a key effector of KSHV-mediated 
host shutoff, results in increased levels of Drosha and decreased levels of KapB 
mRNA during lytic infection (Fig. 3.8B). The most parsimonious interpretation of 
these combined observations is that lytic infection triggers a decrease in Drosha 
protein levels resulting in decreased Drosha-mediated cleavage of KapB mRNA (Fig. 
3.9). Thus, in addition to differences in transcription, differential mRNA cis 
regulation contributes to the robust differences in KapB protein present in cells 
undergoing latent versus lytic infection. 
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To begin to understand the mechanism of decreased Drosha protein levels observed 
during lytic infection, Drosha mRNA levels were tested. TREx-RTA BCBL-1 cells 
were induced to undergo lytic replication, and total RNA was harvested at multiple 
times post-induction. Northern blot analysis showed that Drosha mRNA levels 
decreased during the course of lytic replication, whereas ribosomal RNA levels 
remain constant (Fig. 3.8A). These results are consistent with a smaller pool of 
Drosha mRNA being available to be translated into protein. KSHV, like many other 
viruses, can undergo “host shutoff”, a process in which viral replication inhibits host 
protein expression to foster a cellular environment more conducive to virus 
replication (Glaunsinger and Ganem, 2006). SOX is a viral protein expressed during 
lytic replication that plays a key role in the host shutoff mediated by KSHV. SOX 
functions, in part, by inducing mRNA turnover of a majority of mRNA transcripts. To 
determine if SOX contributes to the decreased Drosha mRNA levels observed during 
lytic infection, an siRNA approach was used to knock down SOX levels. As expected, 
transfection of the siRNA directed against SOX, but not a control siRNA, resulted in 
decreased levels of the SOX mRNA at multiple times post induction of lytic infection 
(Fig. 3.8B). Importantly, cells with decreased levels of SOX had reproducibly higher 
levels of Drosha mRNA and decreased levels of KapB mRNA (Fig. 3.8B). These 
results suggest that Drosha mRNA is susceptible to SOX-mediated turnover during 
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KSHV lytic infection. Finally, during lytic replication, SOX-mediated decreases in 
 -Actin mRNA levels comparable to Drosha mRNA levels were consistently detected 
(Fig. 3.8 A & B), but, unlike Drosha, robust decreases in β-Actin protein levels were 
not observed (Fig. 3.7A). Therefore, differences in the half-life of each respective 
protein could account for these observations.  To test this, I treated TREx-RTA 
BCBL-1 cells with cycloheximide to block protein biosynthesis and measured the 
half-life of β-Actin and Drosha proteins (Figure 3.8C).  This analysis confirmed that 
Drosha has a relatively short half-life of ~4 hours both in latent and lytic infections, 
whereas β-Actin has a longer half-life of >12 hours. These results argue that proteins 
with a shorter half-life will generally undergo more dramatic reductions as a result of 
KSHV-mediated host shutoff. Combined, these finding suggest that SOX-mediated 
host shutoff accounts for at least part of the decreased Drosha levels observed during 
KSHV lytic infection. 
 
What advantage is there in tying the biogenesis of KapB inversely to Drosha activity? 
Kaposi’s Sarcoma, perhaps even more so than many other cancers, is a disease of 
cytokine deregulation. Although the advantage of increased cytokine signaling to the 
virus replication cycle is not fully understood, it is clear that KSHV encodes multiple 
gene products that either are themselves cytokines or have the ability to induce 
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various host cytokines. KapB induces p38 MAP Kinase signaling that can result in 
increased cytokine production (McCormick and Ganem, 2005). However, others have 
suggested (Sadler et al., 1999) and I have confirmed that prolonged high expression of 
KapB is cytotoxic (Fig. 3.6). It is possible that high cytokine levels are beneficial 
during lytic replication when the cells are destined to die anyway, but that high 
expression of KapB during latency would reduce viral fitness. Clearly, low-level 
expression of KapB during latent infection must be advantageous to the virus. Thus, 
the virus has evolved multiple mechanisms, including differential transcriptional 
regulation and mRNA cis regulatory elements (dependent on Drosha-mediated 
cleavage), to ensure consistently low expression of KapB in latency, while allowing 
robust expression during lytic replication.  
 
These findings raise the question of whether viral utilization of Drosha activity serves 
an added advantage over other possible mRNA negative regulatory proteins. For 
example, Drosha activity may serve as a sentinel for cellular states in which the virus 
would benefit from increased KapB levels during latent infection. In this regard, it is 
interesting to note that another viral protein, EBV BHRF-1, is known to have 
pre-miRNAs embedded within the 3’ UTR of its mRNA (Pfeffer et al., 2004). 
BHRF-1 is expressed during some forms of latent infection and has a well-defined 
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mechanism of preventing cell death in the presence of pro-apoptotic stressors (Kelly 
et al., 2009). My results predict that, like KapB, BHRF1 would be expressed at higher 
levels when Drosha activity is low. Thus, presumably cellular physiological states 
during latency benefit both EBV and KSHV by increased expression of 
stress-responsive proteins. To better understand why divergent herpesviruses 
apparently utilize cis regulatory elements that are dependent on Drosha activity, it will 
be imperative to determine the host signaling pathways that regulate Drosha activity, 
and what functions are associated with host transcripts directly regulated by Drosha.  
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Figure 3.8 Decreased mRNA levels and a short protein half-life contribute to 
lower Drosha levels during lytic infection. (A) Northern blot analysis demonstrates 
that both Drosha and β-Actin mRNA levels are lower during KSHV lytic infection. 
The TREx–RTA BCBL-1 cells were treated with TPA and Doxycycline, and cells were 
harvested immediately and then every 12 hours until 60 hours post-induction (HPI). 
(B) KSHV-encoded SOX contributes to decreased Drosha mRNA levels and thus 
increased KapB mRNA levels. TREx–RTA BCBL-1 cells were transfected with a 
negative control siRNA or a SOX-specific siRNA, and then lytic replication was 
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induced. The cells were then harvested at different times post-induction, and total RNA 
was purified for Northern blotting analysis. (C) Drosha protein has a relatively short 
half-life. To inhibit translation, cycloheximide was added to the TREx –RTA BCBL-1 
cells during latency (18 or 36 hours after lytic induction), and the cells were harvested 
for immunoblot analysis. The loading for each time point was normalized to total cell 
number. The calculated approximate half-life of Drosha is 4 hours during either latent 
or lytic infection.  
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Figure 3.9 Model for Drosha-mediated regulation of viral gene expression. 
Efficient miRNA production is favored over KapB expression during latency, whereas 
the opposite occurs during lytic infection. Drosha activity is highest during latent 
infection and low during lytic infection. Along with previously established changes in 
transcriptional activity, Drosha-mediated cis regulation of the KapB mRNA transcripts 
contributes to the low levels of KapB protein that are observed during latency. During 
lytic infection, the degree of Drosha-mediated regulation of KapB levels diminishes. 
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3.4 MATERIALS AND METHODS 
 
3.4.1 Cell Culture and Viral Infection 
TREx-RTA BCBL-1 cells (Nakamura et al., 2003) (provided by Jae Jung, UCLA) 
were maintained in RPMI medium supplemented with 20% FBS, and Hygromycin B 
(50 µg/ml). To induce KSHV lytic replication in TREx-RTA BCBL-1, Doxycycline 
(2 µg/ml) and TPA (20 ng/ml) were added to the medium (Arias et al., 2009). Human 
Embryonic Kidney cells (HEK) 293T cells were maintained in DMEM medium 
supplemented with 10% FBS. Preparations of KSHV viral stocks (Bechtel et al., 
2003) and de novo KSHV infections and adenoviral RTA expression vector 
super-infections (Glaunsinger and Ganem, 2004b) were performed as previously 
described (Glaunsinger and Ganem, 2004b). Adenoviral vectors expressing RTA or 
vGPCR were kindly provided by Britt Glaunsinger, U.C. Berkeley. 
 
3.4.2 Vector Construction and Transfection 
The KapB expression vectors were made by cloning the wild-type KapB 3’ UTR 
(accession: NC_009333.1) or the miRNA-deleted versions of the KapB 3’UTR 
(without miR-K12-10/12 5p and/or 3p sequences) into the pCR3.1- HA-KapB vector 
(a gift from Craig McCormick, Dalhousie University) by overlapping-PCR and 
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confirmed by sequencing. Two different mutations were engineered for each 
pre-miRNA. 10D-1 indicates that for pre-miR-K12-10, a 22 nt deletion of the 
sequence corresponding to the guide strand: TAGTGTTGTCCCCCCGAGTGGC (see 
fig 3.2 for details), whereas 10D-2 indicates a 22 nt deletion of the sequence 
corresponding to the passenger strand: GAGGCTTGGGGCGATACCACCA. 12D-1 
indicates that for pre-miR-K12-12, a 22 nt deletion of the sequence corresponding to 
the guide strand: ACCAGGCCACCATTCCTCTCCG, whereas 12D-2 indicates a 22 
nt deletion of the sequence corresponding to the passenger strand: 
TGGGGGAGGGTGCCCTGGTTGA. DD-1 is a double deletion mutant with deleted 
sequence as shown for 10D-1 plus 12D-1. DD-2 is a double deletion mutant with 
deleted sequence as shown for 10D-2 plus 12D-2. The luciferase reporters were made 
by cloning the KapB 3’UTR into the pMSCV-Luc2CP vector (Seo et al., 2008). 
Drosha (pCK-Drosha-FLAG), and DGCR8 (pFLAG-DGCR8) expression vectors 
(Han et al., 2004) are gifts from V. Narry Kim (Seoul National University). RTA 
shRNA (pshKRTA) and control shRNA (pshCtrl) expression vectors are gifts from 
Ren Sun (UCLA) (Li et al., 2010). The target sequence for RTA is 
CGACAACACCCAAACGAAA, and the target sequence for the control shRNA is 
CAACAAGATGAAGAGCACCAA. To express miR-K12-10 and miR-K12-12, the 
full length KapB 3’UTR was cloned into the pcDNA3.1 vector. Cells (293T) were 
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transfected with Lipofectamine 2000 Reagent (Invitrogen). TREx-RTA BCBL-1 cells 
were transfected by electroporation. TREx-RTA BCBL-1 cells (7 x 10
6
) were 
collected and resuspended in a 0.4 cm Gene Pulser Cuvette (Bio-Rad) with 500 µl of 
serum free RPMI medium. DNA (24 µg) or 700 pmole of siRNA was added to the 
solution and electroporation was applied at 210V, 950 µF for DNA, and 250V, 950 
µF for siRNA. Previously characterized Drosha, DGCR8 or SOX-specific siRNAs 
were used to knockdown Drosha, DGCR8 and SOX levels (Glaunsinger and Ganem, 
2004b; Han et al., 2009).  The electroporated cells were then transferred to a 
microtube, centrifuged and incubated for 20 minutes at room temperature before 
being resuspended in 15 ml culture medium. Under these conditions, the transfection 
efficiency is around 80% as estimated by transfection of an EGFP expression vector 
(pEGFP-C1, Clontech) and analysis using flow cytometry.     
 
3.4.3 Luciferase Assay 
Cells were transfected with pMSCV-Luc2CP-KapB 3’UTR reporters. pcDNA3.1- 
RLuc vector (Seo et al., 2008) was also co-transfected as a control for transfection 
efficiency. Cells were collected 48 hours after transfection and analyzed with the 
Dual-Glo Luciferase Assay System (Promega) according to manufacturer’s 
instructions. Luciferase activity was determined using a Luminoskan Ascent 
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luminometer (Thermo Electronic Cooperation). Results for the reporters are presented 
with the firefly luciferase activity normalized to Renilla luciferase activity. 
 
3.4.4 Immunoblot Analysis 
Approximately 5 x 10
7
 cells were lysed in RIPA buffer (0.1% SDS, 1% Triton X-100, 
1% deoxycholate, 5 mM EDTA, 150 mM NaCl, and 10 mM Tris, pH 7.2). total lysate 
(50µg) was analyzed in 6-12% SDS-polyacrylamide gels, and transferred to PVDF 
membranes (Millipore). Primary antibodies used in this paper are rabbit polyclonal 
anti-RTA antibody (a gift from Don Ganem, UCSF), rabbit anti-KapB antibody (a gift 
from Craig McCormick, Dalhousie U.), rabbit anti-Drosha antibody (Cell Signaling), 
rabbit anti-DGCR8 antibody (Novas), mouse anti-K8.1 antibody (Advanced Biotech), 
mouse anti-β-Actin antibody (Abcam). Blots were probed with a 1:1000 dilution of 
primary antibody in 5% dehydrated milk in Tris Buffered Saline (TBS) and a 1:5000 
dilution for the HRP-conjugated secondary antibodies (Invitrogen). Blots were 
washed in TBS multiple times, incubated with chemiluminescent substrate 
(SuperSignal West Pico or West Dura, Thermo Scientific, Rockford IL) according to 
the manufacturer’s protocol, and exposed to autoradiography film for visualization of 
bands. 
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3.4.5 Northern Blot Analysis 
Small RNA Northern blot analysis was performed as described (McClure et al., 
2011). Northern blot analysis for Drosha, KapB and β-Actin mRNAs were conducted 
using total RNA that was separated on a 1.2% agarose formaldehyde gel and then 
transferred using Whatman TurboBlotter Rapid Downward Transfer Systems. Probes 
(corresponding to nucleotides position 117,564-117,794 from NC_009333) were 
generated by PCR using subcloned KapB 3’UTR plasmid as template and labeled 
with Amersham Rediprime II DNA labeling system (GE Healthcare). β-Actin, Drosha 
and SOX mRNAs were labeled the same way using PCR products (as template) 
generated from amplification with the following primers (β-Actin: 
TGGATGATGATATCGCCGCGCTC, and ACTTCAGGGTGAGGATGCCTCTC; 
Drosha: ACGACCAGACTTTGTACCCTTCC, and 
AAAGTGCCTTGTCCAGGAGGTGC; SOX: AGACTATCTGGTTGACACCCTGG, 
and CTCACTACCAATAAACTCGCCCAC). Probes for miRs-K12-10 and K12-12 
were labeled as previously described (Lin et al., 2010). The intensity of bands were 
detected by PMI imager (Bio-Rad) and analyzed by Quantity One software (Bio-Rad).  
 
3.4.6 Flow Cytometry and Annexin V dying cells assay 
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To identify dying cells, TREx-RTA BCBL-1 cells were collected 48 hours after 
transfection. Cells were washed with PBS buffer, and resuspended in 1 ml Annexin V 
binding buffer (Invitrogen). Propidium Iodide solution 50 µg/ml (Calbiochem) (6 µl) 
and 5 µl of Alexa Fluor 488 conjugated Annexin V (Invitrogen) were added and 
incubated for 15 minutes. Samples were immediately collected and assayed with a 
FACSCalibur flow cytometer (Becton Dickinson, Bedford, MA) using CellQuest Pro 
Software and further analyzed using FlowJo Software. Dead cells and sub-cellular 
debris, as determined from aberrant forward / side scatter profiles, were eliminated 
from further analysis. 
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Chapter 4: Cis-regulatory elements in KSHV PAN RNA 
 
4.1 INTRODUCTION 
When lytic replication is activated in KSHV infected cells, the most abundant viral 
transcript expressed during this phase is a 1077-nucleotide (nt) polyadenylated 
nuclear RNA (PAN). There are ~5x10
5
 copies of PAN RNA per cell (Sun et al., 1996; 
Zhong et al., 1996), which comprise about 80% of the polyadenylated RNA in 
lytically infected cells. PAN is a non-protein coding transcript made by RNA 
polymerase II that contains a 5’ cap and 3’ poly-A tail (Sun et al., 1996). But unlike 
most cellular and viral mRNAs, the PAN RNA is exclusively nuclear, and not 
exported to the cytoplasm (Sun et al., 1996). The function of PAN is still unclear, but 
recent studies have shown that viral late gene expression was inhibited when PAN 
RNA is knocked down, indicating its role in regulation of viral gene expression by an 
unknown mechanism (Borah et al., 2011). The nuclear retention of PAN RNA is 
attributed to a RNA hairpin structure in the 3’ end of PAN transcript, called the 
expression and nuclear retention element (ENE) (Conrad and Steitz, 2005). The 
U-rich loop in ENE interacts with the poly-A tail and protects the PAN RNA from 
degradation (Conrad et al., 2007). From the small RNA deep-sequencing, a low 
abundant small RNA fragment (23 nt) that maps to a putative hairpin structure 
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(named hairpin K) was detected within the PAN transcript. This project is to study the 
role of this cis element in the regulation of the PAN RNA. 
 
4.2 RESULTS 
 
4.2.1 Identification of a novel negative cis-element in the PAN transcript 
I identified a low abundant small RNA (~23 nt) that maps to a putative hairpin 
structure (named hairpin K) within the PAN transcript from my previous work using 
454 next generation RNA deep sequencing to identify KSHV-encoded small 
noncoding RNAs (Figure 4.1). This ~85 nt hairpin K is located ~380 bp from the 5’ 
end and ~400 bp upstream of ENE, and the hairpin K secondary structure is very 
similar to pre-miRNA hairpins, which are cleaved by the host microprocessor. If 
hairpin K is a substrate of the microprocessor, it will be a negative cis-regulatory 
element for PAN.  
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Figure 4.1 Regulatory elements in the KSHV PAN transcript. (A) Secondary 
structure of KSHV PAN RNA was predicted by the Mfold RNA folding prediction 
web server. (B) The 23 nucleotide region highlighted in hairpin K is the small RNA 
identified by 454 deep sequencing and is also the region that is deleted in further 
experiments detailed in this chapter. 
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4.2.2 Mutational analysis of kairpin K within the PAN RNA 
To understand the effect of kairpin K on PAN RNA expression, I generated a PAN 
expressing construct that has a small deletion (23 nt) in the hairpin K. Another PAN 
expressing construct that has an ENE deletion (79 nt) was also made as a control for 
the regulation of PAN gene expression. Total RNA was purified from 293T cells at 48 
hours after transfection and analyzed by Northern blot assay. As previously shown by 
the Steitz lab, deletion of the ENE reduces the steady state levels of the PAN RNA 
(Fig 4.2A) (Conrad et al., 2007; Conrad and Steitz, 2005). On the other hand, the 
Hairpin K mutant strongly increases the steady state levels of the PAN RNA by more 
than 3-fold (Fig 4.2A). Deletion of both elements has an offsetting effect, indicating 
these two cis-regulatory elements function independently on the regulation of PAN 
gene expression. This work demonstrates that hairpin K negatively regulates the PAN 
RNA expression. 
 
 
 
 
 
 
130 
 
 
Figure 4.2 Hairpin K is a negative regulatory element in KSHV PAN RNA. (A) 
Wild-type PAN and hairpin-K-deleted PAN vectors were transfected into 293T cells. 
Total RNA was purified and analyzed by Northern blot assay at 48 hours after 
transfection. Deletion of the 5’arm (highlighted in color in Fig. 4.1B) of hairpin K 
increases the steady state levels of PAN RNA, whereas deletion of ENE decreases the 
steady state levels of PAN RNA as expected. Deletion of both hairpin K and ENE 
negates each effect on PAN expression. The 28S and 18S ribosomal RNAs were 
stained with ethidium bromide and are shown as a loading control. (B) PAN 
expression constructs were co-transfected either with the empty vector (pcDNA3.1) or 
Drosha/DGCR8 expression vectors into 293T cells. Total RNA was purified and 
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analyzed by Northern blot at 48 hours after transfection. The results demonstrate that 
the microprocessor does not regulate PAN RNA expression. The 18S ribosomal RNA 
was stained with ethidium bromide and is shown as a loading control. 
Over-expression of Drosha/DGCR8 was confirmed by Western blot assay. 
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4.2.3 The effect of the microprecessor on PAN expression 
Hairpin K secondary structure is very similar to pre-miRNA, and conveys negative 
regulation on PAN RNA steady state levels. To test whether the negative regulation is 
mediated by the microprocessor, PAN expressing constructs were co-transfected into 
293T cells with pcDNA3.1 or Drosha/DGCR8 expression vector. The cells were 
analyzed by Northern blot assay at 48 hours after transfection. The results show that 
overexpression of the microprocessor does not affect PAN expression (Fig 4.2B). 
This work demonstrates that hairpin K conveys negative regulation on PAN gene 
expression through a microprocessor-independent pathway. 
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4.2.4 The effect of PAN RNA on miRNA biogenesis 
Studies have shown that pri-miRNAs containing the ENE are not efficiently 
processed into pre-miRNAs by the microprocessor. The microprocessor is much more 
active at the transcription site, and the ENE expedites the departure of nascent 
transcripts from their DNA template (Conrad et al., 2006; Pawlicki and Steitz, 2009). 
In other words, the microprocessor loses its enzymatic activity, but still retains its 
binding activity. As such, it is possible that the pre-miRNA-like hairpin K serves as a 
docking site for the microprocessor, but is poorly processed by the microprocessor 
due to the presence of the ENE. If this is the case, the highly-abundant PAN RNA can 
serve as the Drosha sponge during lytic infection and thus block the miRNA 
biogenesis machinery. To test this hypothesis, PAN expression vectors were 
co-transfected along with JCV miRNA expression vectors into 293T cells. Total RNA 
was purified and analyzed by Northern blot assay. The overexpression of the PAN 
RNA does not reduce the levels of newly synthesized JCV miRNA or endogenous 
miR-16-1. Also, the presence of PAN RNA does not  increase the ratio of the 
Kaposin B mRNA to the cleavage products, indicating PAN RNA does not alter the 
activity of the microprocessor. This work suggests that PAN is not a Drosha sponge.  
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Figure 4.3 PAN RNA is not a Drosha sponge. PAN expression constructs were 
co-transfected with JCV miRNA expression vector or Kaposin B expression vector 
(with the wild type Kaposin B 3’UTR) into 293T cells. Expression of newly 
synthesized JCV miRNA and endogenous miRNA miR16-1 and Kaposin B mRNA 
were analyzed by Northern blot. The results demonstrate that PAN has no effect on 
the activity of the microprocessor and the miRNA biogenesis. The loading control is 
ethidium bromide-stained low molecular weight RNA as well as 28S and 18S 
ribosomal RNAs. 
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4.3 DISCUSSION 
 
I have identified hairpin K, a cis-acting element of KSHV PAN RNA. Although 
hairpin K does not seem to be processed by the microprocessor, the low abundant 
small RNA fragment reads (23 nt) derived from hairpin K using 454 next generation 
RNA deep sequencing suggest that hairpin K might be subject to nuclease attack. The 
fact that hairpin K is a cis-acting negative element also supports this hypothesis. It’s 
unclear why KSHV would incorporate a negative regulatory element in the most 
abundant polyadenylated transcript during lytic replication. Hairpin K is likely to play 
a role in addition to regulation of PAN RNA. One possibility is to saturate cellular 
nucleases so that other viral transcripts will be protected from degradation by the 
cellular nuclease(s). PAN enhances viral late gene expression by an unknown 
mechanism. Future work will determine which nuclease(s) are responsible for 
destabilization of PAN RNA via cleavage of hairpin K and whether the presence of 
hairpin K is required for viral late gene expression. Also, although these data do not 
support the model that PAN serves as a sponge, it is possible that Drosha binds to 
hairpin K and protects PAN RNA from processing by the cellular nucleases. Future 
work will be to determine whether the microprocessor binds to KSHV PAN RNA. 
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4.4 MATERIALS AND METHODS 
 
4.4.1 Cell Culture and Transfection 
Human embryonic kidney (HEK) 293T cells were maintained in DMEM medium 
supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS, HyClone, Ogden, 
UT). The 293T cells were transfected at ~85% confluency with Lipofectamine 2000 
Reagent (Invitrogen, Carlsbad, CA). 
 
4.4.2 pre-miRNA Structure Prediction. 
Secondary structure of hairpin K was predicted by the Mfold RNA folding prediction 
web server (Mathews et al., 1999; Zuker, 2003).  
 
4.4.3 Vector Construction 
The PAN expression vectors in this paper were made by cloning the wild type PAN 
(accession: NC_009333.1; promoter sequence included) or hairpin K-deleted or 
ENE-deleted versions of PAN into pBluescript SK (+) vector by overlapping-PCR 
and confirmed by sequencing. ΔK indicates a 23 nt deletion of the sequence 
GTGAAAGGAAAGCAGCGCCCACT. ΔE indicates a 79 nt deletion of the entire 
ENE sequence. ΔKΔE indicates a double deletion of both ΔK and ΔE. Because the 
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native PAN promoter was used, RTA expression vector (which is required for the 
transcription of PAN), was also included in every transfection experiment. 
 
4.4.4 Northern Blot Analysis 
Small RNA Northern blot analysis was performed as described (Grundhoff et al., 
2006b). The probe sequences used in this paper are listed in Table S2. Northern blot 
analysis for Polyadenylated Noncoding RNA (PAN) was conducted using total RNA 
that was separated on a 1% agarose formaldehyde gel and then transferred using 
Whatman TurboBlotter Rapid Downward Transfer Systems. Probes and hybridization 
for PAN were conducted via an identical strategy used for the small RNA Northern 
blot analysis (see Table S2). 
 
 
 
 
 
 
 
 
138 
 
Chapter 5: Thesis significance 
 
Because miRNAs are small, non-immunogenic, and can potentially target many 
transcripts, they are advantageous weapons for the viruses to alter various cellular 
processes as well as regulation of viral genes. It has been shown that KSHV-encoded 
miRNAs are involved in blocking innate immunity, promoting cell cycle progression, 
enhancing host cell survival, and preventing pre-mature entry into lytic reactivation, 
suggesting that the KSHV miRNAs may be involved in the pathogenesis associated 
with KSHV infection. However, these KSHV miRNAs are identified from latently 
infected cells. To identify KSHV lytic specific miRNAs, my approach involves 
making multiple libraries of different size classes allowing me to systematically clone 
pre-miRNAs as well as derivative miRNAs. This allows identification of genomic 
regions that are specifically enriched for miRNA/siRNA-sizes over other (random 
degradation) size classes. I have identified 8 new derivatives from the previously 
described KSHV-pre-miRNAs. Given that many of these are more abundant than 
some cellular miRNAs, it is possible that these newly-identified miRNAs may have 
functions relevant to viral infection. Numerous specifically-processed small RNAs of 
low abundance also were identified. One of these, miR-K12-4-AS, represents a 
KSHV miRNA that is specifically expressed during lytic replication and active within 
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the RISC complex. Future studies are required to determine the functional relevance 
of these RNAs. In this study, a striking coverage of antisense transcription throughout 
the KSHV genome during lytic replication was observed. These data are represented 
by small RNAs, ranging from 18-75 nucleotides in size, span almost every 
macroscopic region of the genome. Recently, there has been much excitement with 
the realization that a majority of the mammalian genome is transcribed– including 
overlapping sense and antisense transcripts (Birney et al., 2007; Maeda et al., 2006; 
Mattick and Makunin, 2006). Similar to their hosts, it is clear that several DNA 
viruses mimic this pattern. The challenge now is to parse out those noncoding 
transcripts that are functionally relevant from those that are just noise. Given the 
emerging similarities between the host and the relatively simpler DNA viral genomes, 
it seems that viruses will once again serve as valuable models for understanding the 
hosts that they infect. 
 
In addition, I have shown that KSHV not only utilize miRNAs, but also the 
miRNA biogenesis machinery to regulate viral gene expression. Previously Drosha 
has been shown to auto-regulate its cofactor DGCR8, but whether Drosha can 
regulate mRNA stability of other genes is still debated. Through this work, I have 
shown that Kaposin B mRNA, encoded by KSHV, is directly regulated by Drosha 
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cleavage, and that the degree of this regulation is variable during lytic or latent 
infection. The differential regulation is achieved by altering the steady-state levels of 
Drosha. I have shown that KSHV lytic protein SOX is involved in the turnover of 
Drosha mRNA. This expands the known functions of Drosha to regulation of viral 
gene expression and sets the stage for uncovering other novel functions of Drosha in 
addition to its established role in miRNA biogenesis. My work suggests, that  
previously unanticipated cis-regulatory functions are likely for some of the over 200 
viral pre-miRNAs that have been discovered.  
 
    KSHV polyadenylated nuclear RNA (PAN) is the most abundant polyadenylated 
RNA during lytic infection. While the detailed functional role is still lacking, PAN 
has been shown to be required for viral late gene expression. In this work, I 
discovered a negative-cis regulatory element in the PAN transcript. It is a mystery 
why a negative cis-regulatory element is engineered within the most abundant lytic 
transcript. Nevertheless, it does suggest that this cis-regulatory element is likely to 
play a role in the KSHV life cycle. A low abundant small RNA fragment (23 nt) that 
maps to a putative hairpin structure (hairpin K) within the PAN transcript has been 
detected from our small RNA library by 454 deep sequencing. This suggests that the 
cis-regulatory element is subject to endonuclease attack. Although hairpin K has a 
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similar structure to a pre-miRNA, my work has shown that PAN RNA is not regulated 
by the microprocessor. Hence, a nuclease is yet to be discovered. The possible 
explanation for incorporation of hairpin K into PAN RNA is to sequester cellular 
endonucleases from other viral transcripts, and allow viral late gene expression. 
Further work will be to determine the presence of hairpin K within PAN RNA is 
required for late gene expression.  
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